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SUMMARY
Two methods of measuring peripheral plasma 
deoxycorticosterone (DOC) concentration have been 
developed using the techniques of gas-liquid 
chromatography with electron capture detection and 
radioimmunoassay* The reliability of these 
methods has been assessed and compared, A number 
of physiological studies have been carried out in 
order to further evaluate the techniques and also 
to investigate some factors controlling the 
peripheral plasma concentration of DOC.
Plasma DOC concentration was consistently 
raised by injection of synthetic P ACTE
(adrenocoï'ticotrophic hormone) or by increasing 
endogenous ACTE by insulin hypoglycaemia.
Infusion of mildly pressor doses of angiotensin, 
dietary sodium depletion and change of posture 
did not affect plasma DOC concentration in normal 
subjects. However, in obese subjects, dietary 
sodium depletion was found to increase plasma DOC 
levels while total starvation caused a marked fall. 
Plasma DOC concentration was also elevated during 
normal pregnancy.
Plasma DOC concentrations were measured in 
a number of hypertensive subjects known to have low 
plasma concentration of renin and potassium and
normal or low aldosterone level. DOG levels were
elevated in 6 out of 21 of these subjects. It
is not known whether these levels maintained over 
a prolonged period of time would be sufficient to 
cause hypertension.
The concentration of DOC in whole blood 
was measured in rats given injections of DOC- 
pivalate or saline in order to investigate the 
suitability of the gas chromatographic technique 
for measurement of DOC in whole blood in the 
study of induced hypertension in the rat. Maximum 
DOC concentration in whole blood in rats
receiving DOC pivalate was 10-12 times
higher than the levels attained in saline injected 
rats and was achieved within 12 hours of injection,
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I. INTRODUCTION
1.1. Biological Importance of Corticosteroids,
The control of electrolyte and water metabolism in 
the living organism is of fundamental importance 
to the function of animal tissues. Any factor 
which influences this metabolism is therefore of 
considerable interest. Early endocrinology revealed 
the importance of the adrenal cortices in this 
respect. In the mid nineteenth century the effects 
of clinical and experimental adrenal insufficiency 
were described (Addison 1855; Brown-Sequard, 1865) 
and their correction by administration of adrenal 
extracts has also long been known (Baumann and 
Kurland, 1927; Loeb, 1932).
Studies of the constituents of blood leaving 
the adrenal cortex and of the adrenocortical 
tissue itself revealed that a number of 
biologically active substances are synthesised 
by the adrenal cortex. These fall roughly into 
three categories, those which affect secondary 
sex characteristics (i.e. oestrogens and 
androgens), those which affect intermediary 
metabolism (i.e. glucocorticoids) anp those 
which affect the metabolism of sodium and 
potassium (i.e. mineralocorticoids). This 
thesis is mainly concerned with the 
mineralocorticoids.
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At least 3 compounds secreted by the adrenal 
cortex have significant mineralocorticoid 
activity. Of these, the last to be discovered 
and most potent is aldosterone and this has been 
studied in great detail, both physiologically 
and clinically, almost to the exclusion of the 
remaining compounds, corticosterone and 
11-deoxycorticosterone (DOC). However, an 
examination of Figure 1 shows that, in addition 
to possessing considerable mineralocorticoid ^ 
potency, DOC occupies a key position in 
adrenocortical biosynthesis. The aims of the 
work described in this thesis were to devise a 
technique of studying the changes of DOC 
concentration in the peripheral circulation in man 
and, using this technique, to study the factors 
I which control these changes.
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PROGESTERONE
21
DOC
18
18-HYDROXY-DOC
11-DEOXy-ALDOSTERONE
U  ^ CORTICOSTERONE
18
18-HYDHOXY-CORTICOSTERONE
ALDOSTERONE
FIGURE 1.
Biosynthesis of mineralocorticoids; hydroxylation 
at positions 21, 18 and 11 on the steroid nucleus 
are indicated hy numbers
M l
1.2. NOMENCLATURE
The following trivial names have been used;
TABLE 1
Trivial Name Systematic Names
Aldosterone
Corticosterone
Deoxycorticosterone
(DOC)
Deoxycortisol
Progesterone
Testosterone
Spironolactone
Dexamethasone
Deoxycorticosterone 
bisheptafluorobutyrate
Progesterone heptafluo- 
robutyrate
Testosterone bishepta- 
fluorobutyrate
Metapyrone
Cortisol
18-hydroxy 
corticosterone
18-hydroxy DOC
\ *
11-deoxy-Aldosterone
11^  , 21-dihydroxy-4-pregnene- 
3 , 20-dione-18-al
11/3, 21-dihydroxy-4-pregnene- 
3, 20-dione
21-hydroxy-4-pregnene-3,
20-dione
17 , 21-dihydroxy-4-
pregnene-3, 20-dione
4-pregnene-3, 20-dione
17^-hydroxy-4-androstene- 
3-one
B~(7^-acetylthio-17c< - 
hydroxy-3“Oxandrost-4-en-17 
yl) propionic acid lactone.
9i>^-fluoro-l6o<~methyl-ll^ ,
1 7 21-trihydroxy-l, 4- 
pregnadiene-5j 20-dione
3 ,21-bis (heptafluorobutoxy)- 
3,5“pregnadiene-20-one
3-heptafluorobutoxy-3, 5- 
pregnadiene- 20-one
3 , 17-bls (heptafluorobutoxy)- 
3, 5-androstadiene
1,2-di (3“Pyridyl)-2-methyl- 
propanone.
11/3 , 17p< , 21-trihydroxy-4- 
pregnene-3, 20-dione
11/3 , 18,21-trihydroxy-4- 
pregnene-3, 20-dione
18, 21-dihydroxy-4- 
pregnene-3, 20-dione
21-hydroxy-4-pregnene-3, 
20-dione-18-al
15
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2* REVIEW OF LITERATURE ON METHODS OF 
ASSESSING SECRETION OF DOC AND 
RELATED STEROIDS„
Assessment of adrenocortical function requires 
both qualitative and quantilhtive analysis of the 
steroid products of this endocrine gland. However, 
as direct access to the adrenal venous effluent is 
rarely possible, particularly in subjects with 
normal adrenocortical function, indirect methods 
must be employed. These fall into two main 
categories, analysis of urine and analysis of 
peripheral plasma.
2.1. Analysis of urine^
Steroids secreted by the adrenal cortex are 
metabolised in the liver and kidneys and excreted 
in the urine. A small proportion of the.total 
steroid is unchanged but most is in the form of 
water soluble sulphates and glucuronicles (McKerns, 
1969)0 The 24-hour urine collection thus contains 
a large quantity of steroids allowing the use 
of less sensitive techniques such as colorimetry 
(Vogt, 1955; Neher and Wettstein, 1956). However, 
the information derived from urine studies is 
limited since small or short term changes in adrenal 
secretion would not be detected due to the time lag 
between secretion and excretion of 
the steroid (Laidlaw et- al, 1954), Two
17
different approaches to urinary steroid analysis have 
been adopted, measurement of the rate of 
excretion and the rate of secretion of steroids*
(a) Excretion rates
The total quantity of a particular compound in 
a 24 hour urine collection is termed the excretion 
rate. This type of measurement has been widely 
used in studies of steroid secreting endocrine 
glands (Biglieri, I965), Unfortunately, most 
corticosteroids yield a variety of metabolities,
The ratios of these may differ in situations of 
low and high adrenocortical activity and in the 
presence of renal or hepatic disease (Cope and 
Black 1958). Estimation of a single metabolite 
may therefore give an erroneous assessment of 
adrenocortical secretion.
Urinary excretion rates of TH-DOC have been 
reported (Harris et al, 196?; Biglieri, 1965?
Nolten et al, 1968; New et al, I969) and the normal 
range was found to be 20-30 ug/24 hours.
(b) Secretion rates*
The principle of isotope dilution has been 
employed in the measurement of steroid secretion 
rate. If a known quantity of radioactively-labelled 
steroid hormone of relatively high specific 
activity is administered at zero time, it will
18
mix with the steroid secreted endogenously and 
will be diluted in proportion to the amount 
secreted. Metabolism of exogenous and endogenous 
steroid is assumed to be identical. Collection of 
urine, usually over 24 hours and measurement of the 
specific activity of a metabolite unique to the 
parent compound under study gives, by a dilution 
factor, the secretion rate of that compound 
(Tait et al, I961). Measurements of the secretion 
rate of DOC have been reported (Bledsoe e"b al,
1966; Crane and Harris, I966; Biglieri et al,
1968) and the normal range was found to 
be 140 - 190 ug/24 hours.
2.2. Analysis of blood and plasma,
(a) Secretion rate studies.
As already mentioned, samples of adrenal venous 
blood are rarely available except at operation.
As the adrenal cortex is extremely susceptible to 
surgical stress (Sayers, 1950) great care must be 
taken in the sampling of the adrenal venous 
effluent and in the interpretation of the results 
of analysis. DOC is particularly sensitive to 
stress (see section 4.2) and this approach is 
therefore unlikely to be of value.
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(b ) Peripheral plasma concentration
For estimation of the concentration of cortico­
steroids in the peripheral circulation whole blood 
or plasma may be used, 1/hen whole blood is allowed 
to stand after sampling corticosteroids adsorb on to 
the erythrocytes (Peterson et ai, 1955; Bush,
1951; Sandberg et al, 1957} combining with the lipid 
membrane of the red cells (V/illmer, I96I), Also, 
whole blood can metabolize steroids in vitro at 
room temperature (Werthessen et al, 1950; Lindner, 
1961; Coyle and Romanoff, 1964), However, using 
heparin or oxalate as an anticoagulant whole 
blood can be stored up to 48 hours in the cold 
without altering the concentration of 
corticosteroids in the plasma phase. Deep-frozen 
plasma may be stored for several months without 
alteration of plasma corticosteroids (Fraser,
1907).
The concentration of corticosteroids in the 
peripheral circulation reflects more accurately 
than secretion rate or excretion rate studies the 
concentratiion of the hormones at tissue level. It 
is-a measure of the equilibrium between secretion 
and catabolism and is therefore affected not only 
by kidney function but also by the function of the 
liver (Brown et al, 1957; Cohn and Bondy, 1958; 
Peterson, 1959) and thyroid (Eik-Nes and Brizzee, 
1956; Heilman et al, I96I),
20
Unfortunately, the concentration of 
corticosteroids are much lower in the peripheral 
circulation than in adrenal venous effluent or 
urine. Consequently, very sensitive techniques are 
required to measure these low concentrations of 
corticosteroids*
2.3. Conclusion.
Measurement of peripheral plasma corticosteroid 
concentrations is a sensitive and convenient method 
of investigating the mechanisms of control of 
secretion of corticosteroids.
In the following section various methods of 
measuring corticosteroid, levels are reviewed with 
particular reference to their applicability to 
the measurement of peripheral plasma concentrations.
3 c PREVIOUS METHOD OF ASSESSING DOG SECRETION
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3. PREVIOUS METHODS OF ASSESSING- DOC 
SECRETION.
3o1o Extraction of corticosteroids
Corticosteroids are l(pophilic compounds dissolved 
in plasma or bound to corticosteroid binding 
globulin (see later). Procedures for their 
extraction from plasma usually involve the use of 
organic solvents such as chloroform, dichloromethane, 
ethyl acetate, and petroleum ether. The choice 
of solvent depends on the compound under investigation 
(Johansson, 1969)0 Partial purification of the 
extract may be achieved by solvent partition which 
removes less polar substances such as cholesterol 
or by alkali washes which removes phenolic compounds 
(Venning, 1954). However, since high concentrations 
of alkali will cause structural alteration of the 
corticosteroids (Mason, 1938; Wendler and G-raber,
1956) the excess alkali should be removed by 
means of a dilute «''acid wash.
Purification of solvents before use may be 
essential. For example, ethyl acetate may form 
peroxide on standing while diehloromethane generates 
phosgene. Both of these contaminants destroy 
corticosteroids.
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Removal of the solvent may be accomplished 
by distillation under reduced pressure at a low 
temperature or by evaporation under a stream 
of nitrogen. It may not be advisable to use a 
stream of air as this may oxidise the 
corticosteroids.
3.2. Chromatographic purification.
Utilising the small differences in polarity of 
the corticosteroid, further purification of 
individual compounds in plasma extracts may be 
achieved by chromatographic techniques such as thin 
layer chromatography (Adamec et al, 1962"CErtel and 
Ungar, 1964), paper chromatography (Neher, 1938;
Bush, 19 61; Zaffaroni, 1953; Eberlein and 
Bongiovanni, 1955)? gas-liquid chromatography 
with fraction collectors (¥einstein et al, 1971)? 
Sephadex (Murphy end Pattee, 1964) and more 
recently high pressure liquid - liquid chromatography 
(Thomas, 1972)/^ Chromatographic purification of 
individual corticosteroid may be enhanced by 
changing the polarity of the compound under study 
by means of chemical modification. In order to 
achieve good purification all contamination in 
the chromatographic media must be removed by 
extensive washing (Holzbauer and Vogt, 196I).
Paper chromatography is a particularly useful 
technique since paper is very easily washed and 
chromatograms may be conveniently run overnight.
2h
3.3. Methods of measuring steroid mass.
Corticosteroids are present in plasma in 
relatively low concentrations together with large 
numbers of compounds of similar chemical and 
physical properties. Accurate assessment of their 
concentrations requires sensitive and specific 
techniques which can be conveniently applied to 
large numbers of samples. Methods of assay can 
be divided into two stages, purification and mass 
measurements. Specificity may be achieved 
either by the use of comprehensive purification 
techniques followed by non-specific assay or by 
the use of highly specific assays requiring 
little preliminary purification. Non-specific 
assays include fluorimetry, saturation 
analysis using plasma proteins^ and double 
isotope derivative assays. Gas liquid 
chromatography and radioimmunoassay are 
specific techniques.
(a) Fluorimetry
A number of corticosteroids are known to 
fluoresce in acid (Reichstein and Shoppee, 1943; 
Sweat, 1954; Peterson, 1957; Goldzieher and 
Beseh, 1958; Muelbaecher and Smith 1970) and 
using alkali, fluorescence can be developed and 
measured directly on paper (fait and Tait, i960).
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The meclianisra by which this fluorescence is 
produced has not been entirely elucidated. (Linford,
1957; Kalant, 1958; Muelbaecber and Smith, 1970), 
although some features of the reactions have been 
investigated and reported (Sandee et al, 1971).
The first quantitative determination of 
cortisol and corticosterone by fluorimetry was first 
developed by Sweat (1954) using dilute sulphuric 
acid. Similar methods have now been developed by 
Peterson (1957), Ely et al (1958), Silber'^et al 
(1958), Braunsberg and James (196O), and Mattingly 
(1962). The original method of Mattingly (1962) 
for the measurement of 11-hydroxy steroids has since 
been modified by James et al (19Ô7) by 
incorporating alkaline extraction of samples 
and the use of strong acid reagents and finally 
automated by Townsend and James (1968). The 
results obtained by this method were found to 
correlate well with true cortisol levels measured 
by double isotope derivative assay (Fraser and 
•James, 1968).
In general, fluorimetric techniques are simple, 
rapid and permit the processing of large numbers of 
samples. Although for pure steroids, as little 
as 10 ng. of pure steroid can be detected, the 
practical limit of sensitivity of these methods is much 
higher when applied to biological samples due to non­
specific interference which appears to derive from various
26
sources including thin layer and paper chromatograms 
(Braunshcrg and James, IRôO)*
Muelbaecber and Smith (1970) reported details 
of fluorescence of 11-deoxycorticosteroids in 
perchloric acid using 11-deoxy-cortisol as a 
representative steroid. However, the sensitivity 
attained would not be adequate for the measurement 
of DOC in peripheral plasma again because of the 
limitations imposed by non specific fluorescence.
(b ) Double isotope derivative assay
Double isotope derivative assays for
steroids involve the use of a radioactively-labelled
form of the steroid as a measure of recovery
throughout the method. Mass measurement is
accomplished by formation of a derivative of the
steroid using a radioactively labelled reagent.
Double isotope derivative assays of steroids
were first introduced by Peterson (i960) and
Bojesen and Deap- (I96I) and have since found wide
application to the measurement of steroids in
biological samples.
The method of Peterson et al (196O) involved
addition of (^H)- aldosterone to the samples as an
1 h.
index of recovery and the formation of the ( C)~
acetate derivative of the endogenous steroid. The 
sensitivity of this method was limited by the specific 
activity of (^"C)-acetic anhydride. The sensitivity 
of the method was improved by inversion of 
the isotopes (Kliraan and Peterson, I960)
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Peterson, i960). This has formed the 'basis of a 
number of methods for measuring corticosteroids 
by double isotope derivative assay procedures 
(Koding et al 1962; James and Eraser, I966;
Coghlan and Scoggins, 196?; Fabre et a l , 1969)0 
However, due to the relatively low specific 
activity of corticosteroids, a significant
quantity of radioactivity labelled steroid is 
required for estimation of recovery.
1Z1
Bojesen and Begn (196I) introduced ' I- p -
iodosulphonates as recovery standards which were
added after estérification with S - p - iodo-
sulphonylic anhydride. Incomplete estérification
obviously could cause serious errors in this method, 
35S“* p toluene sulphonates also form the basis 
of a sensitive method developed by Bojesen (1965). 
Thiosemicarbazones, which have been used for the 
measurement of progesterone (Riondel et al, 1965) 
and testosterone (Riondel et al, I963), would also 
be a useful derivative for the estimation of 
corticosteroids in plasma.
Double isotope derivative assays involve 
a non-specific mass determination; therefore 
specificity can only be attained by using extensive 
chromatographic procedures. However, the 
technique can be applied readily to the simultaneous 
analysis of several steroids in one sample.
For example, James and
28
Fraser (1966) developed a double isotope derivative 
assay for the simultaneous determination of aldosterone, 
cortisol and corticosterone. This technique possesses 
adequate specificity and accuracy for the 
estimation of these steroids in peripheral plasma.
Recently, Oddie et al (1972) reported a method 
for the simultaneous determination of aldosterone, 
corticosterone, cortisol, deoxycorticosterone and 
deoxycortisol in peripheral plasma by double 
isotope derivative assay using 10 - 30 mis of plasma.
The normal range of plasma DOC was reported to be 
6,3 - 1.0 ng/100 mlo
Although double isotope derivative assay is a 
very sensitive technique which permits estimation 
of corticosteroids like aldosterone and DOC in 
peripheral plasma, specificity can only be achieved 
by inclusion of several chromatographic stages. 
Consequently, this type of method is laborious and 
time consuming and was considered inconvenient for 
routine analysis of plasma samples,
(c ) Saturation Analysis
Steroids are bound reversibly and with variable 
affinity to protein molecules. If a known quantity 
of steroid-binding protein is saturated with 
radioactivity labelled hormone and a quantity of 
unlabelled quantity is then added, this latter
compound will compete with the labelled hormone for 
binding sites. At equilibrium, the quantity of 
labelled hormone remaining bound to the protein will 
be inversely proportional to the quantity of 
unlabelled substance added. This principle is 
called saturation analysis. Two types of methods have 
developed depending on whether a specific antibody 
or a naturally occurring binding protein is used, 
namely protein binding and radioimmunoassay,
(l). Protein binding using plasma proteins,
Two steroid binding proteins have been found in 
plasma, namely, albumin and corticosteroid binding 
globulin (Eik-Nes et al 1954; Daughaday, 1958)* Both 
of these proteins bind cortisol although the affinity 
varies from species to species (Seal and Doe, 1965; 
Murphy, 1967). For example, monkey GBG has a much higher 
affinity for corticosterone than does human GBG.
GBG has a relatively high affinity for cortisol but a 
low capacity, whereas albumin has a low affinity 
but a high capacity for cortisol. The steroid 
binding properties of these proteins (Daughaday,
1958; Slàunwhite and Sandberg, 1959; Sandberg et al,
1957; Chen et a l , 1961) have been exploited as a 
means of measuring plasma corticosteroids by 
saturation analysis techniques.
Most protein-binding methods are based on the 
early work of Murphy and colleagues (1963? 1964)
.30
who reported a technique for plasma cortisol 
measurement. This involved extraction of plasma 
followed by chromatographic purification of cortisol.
An aliquot of this extract was incubated with ( *0)-
cortisol and corticosteroid binding globulin and then 
bound and free cortisol were separated by dialysis 
techniques. The method was later improved by the use 
of (^H)“ cortisol of a much higher specific activity 
than cortisol thus increasing sensitivity.
Further improvement was achieved by the use of simpler 
methods of separating free and bound steroid such 
as gel filtration or adsorption onto an insoluble matrix, 
for example, dextran-coated charcoal, florisil or 
Lloyds reagent (Murphy, 1967).
Protein binding is a non-specific mass 
measurement, and as was indicated earlier, 
specificity can usually be attained by the inclusion 
of one chromatographic purification step. Beitins 
et al (1969) showed that cortisol levels measured 
by double isotope derivative assay (Klinian and 
Peterson, 1960), colorimetry (Porter and Silber,
1950) and also by protein binding compared well at 
lowland normal cortisol levels. In such samples 
chromatographic purification prior to incubation was 
not necessary. However, in samples containing 
increased concentrations of cortisol a good correlation
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between protein binding and. the other two methods was 
obtained only when a paper chromatography step was 
included in the method prior to incubation.
Recently, Brown and Strott (l97l) reported a 
competitive protein binding method for measurement 
of peripheral plasma DOC concentration. Specificity 
was achieved by inclusion of two chromatographic steps 
prior to incubation of samples with (^H)- 
deoxycorticosterone and corticosteroid binding 
globulin. Normal range of plasma DOC was f^und to be 
5 - 1 0  ng/lOO ml. However, using a 10 ml, sample of 
plasma the method was not sensitive enough to measure 
less than 5 ng/100 ml. Consequently, the usefulness 
of the technique was restricted since in 40^ of 
analyses DOC was undetectable.
Protein binding methods are generally simple, 
rapid and suitable for analysis of large numbers of 
samples. Again, specificity can be achieved by 
introducing chromatographic purification. 
Unfortunately, this type of method does not appear 
to possess adequate sensitivity to detect small 
changes in plasma concentration of steroids such as 
DOC or aldosterone and therefore would not be 
suitable for the present study.
I ) ' K n d 10 1 mmu no assay.
Radioimmunoassay is a form of saturation analysis 
involving competitive inhibition of binding between
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antibodies and specific radioactive antigen, by 
unlabelled antigen. The use of antibodies raised 
to certain steroids confers on this type of method 
an inherent specificity which is not found in 
conventional protein binding methods using naturally 
occurring proteins (see preceding section). Raising 
and testing of antisera, development of a practical 
assay and assessment of its reliability pose a variety 
of problems which will be briefly reviewed,
A, Production of Antibodies,
Steroids are haptens which can be rendered . 
antigenic by coupling them to large carrier molecules 
such as proteins (Erlanger et al, 1957; Erlanger 
et al, 1959; Goodfriend and Sehon, 1958), In 
order to achieve antisera of good titre, avidity 
or sensitivity and specificity, careful choice of 
antigen, carrier protein, injection programme, 
and experimental animal are essential. Some of these 
decisions are purely arbitrary, and the success or 
failure of different protocols is often difficult to 
explain.
1. Antigen synthesis.
The early work of Bieser et al (1959) indicated 
that antisera may be most specific for those parts of 
the steroid molecule which are remote from the point 
of attachment of the carrier protein. The stereospecific 
property of antisera which has been further confirmed
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by the work of Midgley and Niswender (1970) 
shows that the unique chemical features of a 
given steroid should be prepared as intact as 
possible in formation of steroid-protein 
conjugates as antigens.
Conjugation of proteins to steroids. Most of 
the conjugation methods are based on the pioneer 
work of Erlanger et al (1957, 1959), Goodfriend 
and Sehon (1958, I96I) and Lieberman et al (1959) 
who developed methods of forming stable covalent 
linkages between proteins and steroids. Earlier 
attempts to induce antibody synthesis to andro- 
stenediol were unsuccessful, presumably due 
to the ready hydrolysis of the steroid protein 
linkage.
Lieberman et al (1959) developed a 
mixed anhydride reaction suitable for coupling 
oximes or henisuccinates directly to amino 
groups of lysine^residues in the protein molecule. 
This type of reaction is obviously suitable for any 
steroid which possesses a hydroxyl or carbonyl 
functional group. However, the reaction involves 
the use of strong alkaline conditions at which 
all steroids may not be stable, A similar 
condition applies to the Schotten-Baumann reaction 
used to link proteins to the acyl 
chloride derivatives of steroids
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Goodfriend and Selian (1958, I9 6 1) used a 
carbodiimide condensation reaction to link 
protein and steroid. This technique was further 
developed by Gross et al (I9 6 8) who coupled 
diazobenzoic acid to oestradiol - 1?P at position 
2 to yield an oestrogen azobenzoyl derivative 
which they linked to proteins through the 
azobenzoyl carboxyl by carbodiimide condensation.
Conjugation of the protein to the steroid at 
position 6 requires the formation of a suftable 
functional group.
In any steroid-protein conjugate used for 
antibody formation the steroid protein ratio may 
be important in the induction of antibody synthesis. 
For example, Midgeley and Niswender (1970) failed 
to induce antibody formation usfng corticosteroid - 
bovine serum albumin conjugates in which the 
steroid-protein ratio was 10:1, whereas, Erlanger 
in an otherwise ^ similar experiment successfully 
raised antibodies using conjugate in which the 
steroid protein ratio was 20-30:1, This ratio may 
be estimated by including in the synthesis of the 
steroid derivative a quantity of radioactively 
labelled steroid which allows the quantity of 
steroid in the final conjugate to be calculated. 
Other methods include the dinitrophenylation 
technique of Sanger (1945, 1949) and 
quantitative uv absorption methods.
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2. Other factors influencing production of 
specific antibodies.
Carrier Protein. A complete immune response 
requires the recognition and participation of the 
carrier protein (Landsteiner, 1945; Green et al,
1968). As the steroid itself is not immunogenic 
in the natural state, it requires to be linked 
to a larger molecule such as a protein. This 
stimulates antibody production by the macrophages.
Serum albumin which itself is immunogenic 
generally gives good results (e.g, Goodfriend 
and Sehon, I9 6 1), It has been postulated that 
direct exposure of lymphocytes to the antigen 
leads to tolerance whereas exposure to the 
immunogen via the macrophage leads to immunity 
(Dresser, I9 6 2),
Choice of animal species. As immunity depends on 
the responsiveness of the individual animal to the 
antigen and is genetically determined, probably 
by a single gene, certain inbred strains may 
synthesize antibodies to a particular steroid antigen 
while others may not (Green et al, I9 6 8). Random- 
bred strains are usually the safest choice,.
The choice of species must also depend on 
the ease of handling the animal, the ease of production 
of antibodies, and the volume of blood which can be 
obtained. Rabbits have been used successfully for
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the production of antibodies by many workers. They 
are easily handled and provide reasonable volumes 
of serum, Guinea pigs have also been widely 
used but provide smaller volumes of serum which 
must be obtained by cardiac puncture. Sheep are 
reported to yield very high antibody titres 
and also provide very much larger volumes of serum.
Immunisation programme, The antibody response to 
an injected immunogen is greatly enhanced by use of 
an adjuvant such as a mineral oil or aluminium 
hydroxide. The most common one is Freund's complete 
adjuvant (Freund, 1931) which consists of paraffin 
oil, a neutral detergent and killed mycobacteria.
The antigen, injected in a stable emulsion in 
Freund's complete adjuvant, is slowly released 
over a period of weeks. The adjuvant also 
facilitates phagocytosis of the immunogen by ' 
macrophages and causes local granulomatous lesions 
which may act a locus of antibody formation 
(Frei et al, 1963),
Few critical studies have been made of the 
route of administration of immunogen, among the 
commonest being subcutaneous and intradernial sites.
Most workers have used 1 mg^ or less of conjugate for 
the initial immunisation followed by 0,5 mg, or 0,25 
rag, conjugate for subsequent immunisations. However, 
Vaitukaitis et ,al (l97l) reported production of antisera 
to testosterone using a total of 100 ug, immunogen
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for each immunisation which was given intradermally
at 20 - 30 sites.
The timing of injections is also important. Due 
to the slow sustained release of antigens from the 
Freund's emulsion, antibody levels rise to a 
maximum 6 weeks after the first immunisation.
Thereafter antibody levels attain a maximum 7 - 10 
days after each booster injection when blood samples 
may be taken for testing of antisera,
B, Testing of Antisera
Titre. The presence of antibodies may be demonstrated 
by quantitative preciptin or haeniaglutination 
techniques (Lieberman et al, 1959; Goodfriend and 
Sehon, 1961; Ferin et al, I9 6 8; Gross et al, 1968), 
However, if the antiserum is to be used for radio­
immunoassay, the presence and titre of antibodies 
is more conveniently demonstrated by incubating 
serial dilutions of the antiserum with radio- 
iodinated antigen (Midgley and Niswenden I9 6 9;
Niswender and Mfdgley 1970) or with tritium - 
labelled hapten or hapten which is protein bound.
This is usually expressed as percentage bound or 
as the ratio of bound; free and plotted against the 
corresponding dilution of the antiserum.
Specificity, The specificity of the antiserum may 
be determined by incubating it in serial dilutions with
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a series of tritium-labelled steroids and 
constructing a dilution curve as shown in section 4,2, 
Obviously, all steroids cannot be tested and the 
obvious choice would be those with similar 
functional groups and those of similar polarity 
which may interfere in the radioimmunoassay of the 
steroid under study. Steroids present in large 
concentrations must also be tested since a small 
proportional cross reactivity could yield a false 
positive result by virtue of the mass of steroid 
present.
Sensitivity. The effective avidity of an antiserum 
used for radioimmunoassay is obviously important when 
very low concentrations of steroids require to be 
measured, Berson and Yalow (1964) first suggested 
that the steepness of the descending part of the 
titration curve is an indication•of the sensitivity 
of the antiserum. However, it has since been shown 
from a theoretical point of view and by practical 
means that it may^not always be an accurate guide 
(Greenwood, I9 6 8; Berson and Yalow, I9 6 8), Assuming 
a bimolecular reaction and that the concentration 
of labelled antigen is small compared to that 
of antibodies present in all tested dilutions it 
can be shown that the: ratio of bound : free must fall 
proportionately with dilution of antibodies 
regardless of the equilibrium constant of the antibody
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antigen reactions. Therefore, on dilution of 
antisera, per cent hound steroid will decrease in 
the same way in all antisera and all curves will 
appear parallel under these conditions, A more 
accurate guide of sensitivity is to incubate the 
antiserum with varying amounts of radioactively 
labelled antigen. The minimum amount of labelled 
antigen required to give a separate curve indicates 
the quantity of labelled antigen required to give 
maximum sensitivity,
C, Use of Antisera,
Preparation of Samples . The extent to which samples 
must be purified depends on the specificity of the 
antiserum in use. With a highly specific antiserum 
little purification of sample may be required.
However, most methods include a chromatographic 
step in order to achieve good specificity. For 
example, Abraham et al (1970), in the measurement of 
plasma oestradiol 1?P concentrations in peripheral 
plasma.jcompared results obtained with and without 
a chromatographic step in the method. Results 
correlated well when levels were normal or low, but 
anomalously high results were often obtained in 
women during pregnancy when no chromatographic step 
was included.
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Although the use of chromatographic 
purification will improve the specificity of radio­
immunoassay by eliminating interference from most 
other steroids, it may also introduce non specific 
interference from the chromatographic medium in 
use thus causing measurable blank values. Careful 
purification of the chromatographic medium is 
essential to avoid this type of contamination,
Puruyama and Nugent (l97l) used small alumina 
columns which were conveniently cleaned by solvent 
washing and gave low blank values, Sephadex LH-20 
columns have also been used and reported to give 
very low blank values (Mikhail et al, 1970; Wu 
and Lundy, 1971; Ito et al, 1972), Celite columns 
(Abraham et al, 1971; Tulchinsky and Abraham
1971), paper chromatography (Ito et al, 1972;
James et al, 1971) and thin layer chromatography 
(Farmer et al, 1972) have also been employed,
Johanssen et al (I969) using petroleum 
ether of a precise boiling range, developed 
extraction systems which allow fairly specific and 
quantitative removal of individual steroids.
Specificity can be achieved in this way without 
introducing problems of non-specific interference. 
Similarly, high pressure liquid - liquid chromatography 
may also offer convenient methods of purifying samples 
prior to assay.
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Purification of antisera. Animals injected with 
«steroid - protein conjugates develop antibodies 
not only to the steroid but also to the carrier 
protein. The non-specific binding of the latter 
may interfere with the assay. A convenient method 
of removal is to expose the antiserum to bovine 
serum albumin and then centrifuge, thus precipitating 
the interfering antibodies before using the serum for 
RIA (Furuyama et al, 197O).
Treatment of serum with Rivanol (2-ethoxy-6, 
9-diamino-acridine lactate) was reported (Horejsi 
and Sraetna, 1956) to precipitate all serum 
proteins except gamma globulins, Kaldor, Saifer 
and Vecsler (I96I) demonstrated that the mechanism 
of action of Rivanol precipitation of bovine serum 
albumin is related to the number of carboxyl 
groups not interacting with amino groups, Rivanol 
forms an insoluble cationic complex with the protein, 
Rivanol treatment is a useful means of purifying 
antisera (Abraham, I9 6 9).
Assay Systems, Mass measurement by radioimmunoassay 
involves incubation of samples with radioactively 
labelled antigen and antibodies followed by 
separation of antibody bound and free steroid. 
Procedures using various systems of incubation and 
separation of bound and free have been developed. 
Variables such as temperature and time of incubation.
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form of the antibody and amount of protein present 
affect the equilibrium of the reaction and require 
consideration.
Conditions of incubation. The pH and ionic 
strength of buffer used for incubation can alter 
the antibody-antigen reaction (Pressman and 
Grossberg, I9 6 8; Ganguly et al, 196?Î Ganguly and 
¥estphal, 1968), Therefore, investigation of the 
effect of alteration of pH on the extent of binding 
of the steroid may be necessary in order to 
obtain optimal assay conditions.
The rate of the first order reaction between 
antibodies and antigen is temperature dependent. 
Incubation at 37^C (Bayard et al, 1970) or at room 
temperature (Mikhail et al, 1970; Yoshizawa and 
Fishman, 1971) will achieve equilibrium more 
rapidly than at 4^C (Mayes and Nugent, 1970).
However, a stable temperature, essential in order 
to maintain reproducibility may be achieved most 
conveniently at 4^0,
Addition of radioactively labelled antigen. The 
labelled antigen may be added to the plasma extract 
prior to incubation or may be included in the dilute 
buffered antiserum. Rodbard et al (I97I) 
investigated this problem by kinetic analysis methods 
and using computer simulation studies. They
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demons trated that improved sensitivity can be 
achieved by delayed addition of radioactivity 
labelled antigen, thus providing a non 
equilibrium type assay.
Separation of bound and free steroids. Many 
radioimmunoassay methods involve separation of 
bound and free steroid by precipitation techniques. 
Free steroid may be removed by adsorption on 
to an insoluble matrix such as florisil (Bayard 
et al, 1970; Ito et al, 1972) or dextran-noated 
charcoal (Abraham et al, 1971; Wu aid Lundy, 1971; 
.Yoshizawa and Fishman, 1971)* Bound steroid may 
be removed by protein dénaturation using half­
saturated ammonium sulphate solution (Mayes and 
Nugent, 1970: Furuyama et al, 1970),
Midgley and Niswender (I969) developed novel 
methods of separating bound and free using a double 
antibody technique. Samples were incubated with 
excess bovine serum albumin and antibody specific 
to the steroid under study. After 24 hour 
radioiodinated steroid bovine serum albumin conjugate 
was added and incubated again before addition of 
sheep anti-rabbit X  globulin serum. After a further 
3 days the samples were centrifuged and counted to 
obtain the per cent bound steroid. Unfortunately, this 
technique is not as convenient as the other simpler 
methods of separating bound and free. It is, however,
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a very specific method suitable for radioimmunoassay 
of many haptens.
Solid phase methods. Abraham et al (1970) reported 
a solid phase radioimmunoassay of oestradiol - 17p 
using antibody coated tubes (Catt and Treager,
1967). The samples are incubated with the antibody 
after which the buffer containing the free sterpid is 
quantitatively removed. This technique allows 
equilibration and separation of bound and free 
steroid in a single step. However preparation of the 
tubes requires larger quantities of antibodies 
initially in order to achieve adequate and 
reproducible coating.
Solvent partition. Banks et al (l97l) developed a 
rapid radioimmunoassay of aldosterone in which 
toluene scintillator was used to separate bound and 
free steroid. The technique is simple and obviously 
useful for analysis of large numbers of samples.
Application to the measurement of plasma DOC 
concentration. Recently, James et al (I97I) reported
a radioimmunoassay of plasma DOC. Based on the 
initial techniques of Mayes et al (1969) antibodies 
were produced in the rabbit using DOC - 3 - 
carboxymethyloxime conjugated to bovine-serum' albumin 
as antigen. The method involved purification of 
plasma extracts by paper chromatography prior to 
incubation with antiserum and tritium-labelled DOC
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in borate buffer. Bound and free steroid were 
separated using ammonium sulphate precipitation*
Specificity was determined by comparison of results 
with those obtained by double isotope assay and 
gas chromatography (see section 4 ). Close 
correlation of results indicated good specificity. 
Within batch precision was - 0.83 (S.D.) ng/100 ml 
and between batch precision ranged from 4,4 - 
0 .9 7 (S.D.) to 7.8 - 1.4 (S.D.) ng/100 ml. Normal 
range of plasma DOC concentration was reported to 
be 1 - 12 ng/100 ml with a mean of 5 ng/100 ml.
Reliability of radioimmunoassayI
Specificity, Radioimmunoassay is a specific mass 
measurement. Evidence of specificity can only be 
obtained by cross reaction studies and comparison 
of results with those of more physico-chemical 
techniques such as gas chromatography. However, 
when a chromatographic step is employed prior to 
assay specificity can be further improved.
Sensitivity. Radioimmunoassay is a highly sensitive 
technique which allows quantitation of steroid 
present in a few ng/100 ml plasma and requires only 
a few ml, of plasma. For example, several methods 
have been reported for radioimmunoassay of aldosterone 
(Mayes et al, 1970; Farmer et al, 1972; Ito et al,
1972) using between one and five millilitres of plasma.
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Convenience, Radioimmunoassay is a rapid technique 
which is much less time-consuming than double 
isotope derivative assays and technically simpler 
than gas chromatographic techniques. However, 
production of antisera may he costly, laborious and 
time consuming.
Due to the simplicity of the techniques and 
the small size of sample needed, radioimmunoassay is 
suitable for duplicate analysis of samples which may 
improve accuracy and reliability of the me-thod.
Conclusion. Radioimmunoassay techniques offer à 
specific and sensitive method which is suitable 
for measurement of peripheral plasma concentrations 
of steroids especially where small or short term 
changes require to be measured. As only a few 
millilitres of plasma should be,required repeated 
sampling would be feasible.
From these criteria, it was decided to develop 
antisera to DOC and a radioimmunoassay for plasma 
DOC, Development and assessment of this method is 
described in section 4,
(d) Gas liquid chromatography (G-LC) of corticosteroids,
GLC has found particularly useful application to the 
study of plasma steroids since it combines the 
features of excellent chromatographic separation 
and very sensitive detection.
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Principle. The principle of GLC is basically 
similar to that used in all types of chromatography, 
A group of steroids under study is mixed in 
gaseous or vapour phase with a small volume of an 
inert mobile gas phase which then passes through 
a column packed with a solid support coated with 
stationary phase. The components of the steroid 
mixture interact to varying degrees with the 
stationary phase as they pass through the^column, 
the affinity of each component for the stationary 
phase determining the extent of interaction and 
this produces a relative retardation on the column. 
Depending on the relative retardation of individual 
steroids chromatographic separation is achieved.
The eluate from the column then passes through a 
detection system which responds to each component. 
The response is potentiometrically recorded.
The retention time of any steroid, that is, 
the time elapsing between injection of the sample 
and detection of the appropriate peak on the 
recorder, is characteristic of the steroid and may 
be used to identify the steroid.
Factors influencing retention time. The retention 
time of any particular compound on GLC depends 
upon a variety of factors including the 
characteristics of the stationary phase in the 
column, carrier gas flow rate and temperature.
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Stationary phase. Selective and non-selective 
stationary phases are available. The separation of 
steroids on a selective phase depends primarily on 
the active steroid groups such as hydroxyl 
or carbonyl groups. Selective phases include OV-l?, 
OV-22, OV-2 25 which are silicones with polar 
characteristics. Separation on non-selective 
columns such as OVl, XE-60 or SE-3 0 depends 
mainly on the molecular weight of the steroid.
These phases are non polar,
The stationary phase is coated on an inert 
support such as diatomaceous earth and then packed 
in silanised glass columns.
Longer retention times and better chromatographic 
separation of steroids may be obtained by using long 
columns although this is also affected by the 
efficiency with which it is packed.
Temperature and carrier gas flow rate. Raising the
column temperature or increasing the carrier gas
r-
flow rate decreases the retention time of a 
steroid. Optimal chromatographic separation can be 
achieved by manipulating these two variables.
Retention Index. There are various standard methods 
of denoting the retention values of a particular 
steroid on a particular column, for example Kovats 
Retention Index (Kovats, 1958) describes the 
retention time of a compound by comparison with those
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of straight chain alkanes.
Quantitation by GLC. The height or area of a peak 
obtain on GLC for a particular steroid is a 
measure of the quantity injected on the column. 
Therefore, samples may be measured quantitatively 
by comparison of peak height or area with that of 
standard injections of the same steroid. An 
internal standard of similar chemical characteristics 
and similar but not identical retention time 
is added to each sample and standard in order 
to account for losses on the column due to 
decomposition or adsorption and losses on injection 
of samples.
Development of GLC for measurement of steroids. The 
first practical separation of steroids by GLC was 
achieved by Van den Heuvel et al in i9 6 0.
However, many steroids were subsequently found to be 
unstable when chromatographed on SS-30 at 220^0.
For example, cleavage of the side chain of 
corticosteroids occurs, giving rise to the 
corresponding 17-ketosteroids, This was confirmed 
by Luetscher and Gould (1964) who compared the
1
retention times with those of the corresponding 
androstenes. The problem of instability of 
corticosteroids on the GLC column, 
has been solved in a number of ways.
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Oxidative cleavage. Oxidative cleavage of the side 
chain of corticosteroids was reported (Merits, 1962) 
to yield derivatives which were stable on gas 
chromatography. The corticosteroids were converted 
into the corresponding etio-cholenic acids which, 
on estérification with diazomethane gave 
stable methyl esters which were suitable for 
gas chromatography. However, aldosterone and 
18-“liydroxydeoxycorticosterone were oxidised to 
internal esters or lactones which were stable 
without estérification,
Kittinger (1964) exploited this oxidation 
reaction for the estimation of steroids produced 
by the rat adrenal gland and later for simultaneous 
estimation of several corticosteroids (Kittinger, 
1967; Kittinger and Beamer, 1968).
Bailey (1963» 1964) used sodium bismuthate 
for oxidative cleavage of the side chain of cortisol 
and its metabolites to estimate these compounds 
in urine by gas chromatography.
Formation of stable derivatives. Acetates (Brooks, 
1 9 6 4, 1965) and triraethylsilyl ethers (Luukkainen 
et al, 196I; Rosenfeld, 1964; Brooks et al, I9 6 7) 
were also introduced as stable corticosteroid 
derivatives suitable for GLC, Rosenfeld (1964) used 
the trimethylsilylether for the estimation of urinary
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17-hyclroxy steroids. Steroid methoxime - 
trimetliylsilylethers have also been extensively used 
in the study of urinary steroid profiles (Horning 
and Gardiner, 1965),
Kirschner and Pales (1962) prepared the 
bismethylenedioxy derivatives of 17-hydroxy steroids. 
They demonstrated the use of this stable derivative 
in the estimation of cortisone in guinea pig urine 
by gas chromatography. Unfortunately, cortisol, 
11-deoxycortisol and tetrahydrocortisone were found 
to be unstable during gas chromatography using a Ifo 
SE-3 0 column.
Conclusion. Much of this early work in the 
development and validation of corticosteroid 
derivatives served to demonstrate the feasibility 
of the technique for the estimation of steroids in 
biological samples and also illustrate the 
inherent specificity of the method in that the 
steroid could be^characterised on the basis of 
retention time.
Using conventional detector systems such as 
flame ionisation or p ionisation gas chromatographic 
techniques do not possess adequate sensitivity to 
detect and measure the levels of many corticosteroids 
present in peripheral plasma. A great improvement 
in the sensitivity of GLC analysis has been achieved 
/ by the introduction of the electron capture detector.
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Principle of the electron capture detector. The 
electron-capture detector employes a source of low- 
energy free electrons such as tritium foil or
^^Ni isotope. As a molecule passes through the , 
detector it will capture electrons by one of 
two processes, either
(a) e + AB —^  AB” + energy
or
(b) e A- AB —V»- A + B* - energy.
where AB is the molecule under study. The ion AB
or B , being less mobile than the free electron, 
reaches the collector plate more slowly than the 
free electron. As a result, there is a decrease 
in current across the detector cell proportional 
to the number of electron-capturing molecules passing 
through the detector cell.
Electron capture detection of steroids. On the 
observation that some organic vapours capture 
electrons it was postulated that submicrogram 
quantities of steroids should be detectable by 
electron capture following gas chromatography 
(Lovelock and Lipsky, I96O; Lovelock, 196I;
Wentworth and Becker, 1962; Lovelock et al,
1963; Landowne and Lipsky, I963). Formation of 
derivatives capable of electron capture would
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enhance the level of sensitivity of detection by 
gas chromatographic techniques. Obviously groups 
containing several halogen atoms which have a high 
electron affinity would be most electron 
capturing. Resonance stabilisation of the negative 
charge via conjugated double bonds may also 
enhance electron capturing power of a molecule.
Formation of electron capturing derivatives.
Halo-acetate derivatives. Landowne and Lipsky (1963) 
prepared a series of haloacetates of cholesterol 
and studied the relative molar response to 
electron capture detection for each derivative. 
Surprisingly, the order was found to be
monochloroacetate > dichloroacetate > monobromoacetate > 
trichloroacetate > trifluoroacetate. The
unexpected order of molar response to electron 
capture detection was thought to be due to attachment 
of electrons to the carbonyl carbon atom instead of 
the halogen atoms. Increased polarity of the 
double bond caused by the interspacial electron 
attraction of the halogens would be greatest for 
monochloroacetate,
Subsequently methods were developed for the 
estimation testosterone (Brownie et al, 1964), 
progesterone (van der Molen and Groen, 1965) and 
oestradiol (AAkvaag et al, 1964) in human plasma.
In other studies van der Molen et al (1965)
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reported that steroid monochloroacetates were 
stable derivatives suitable for electron capture 
detection and which allowed precise measurement 
of 1 - 10 ng. amounts of steroid,
Silyl ethers. Thomas et al (1966) investigated 
the molar response to electron capture detection 
of various halogenated silyl ethers of testosterone. 
These derivatives were more responsive to electron 
capture detection than haloacetates. Using the 
iodomethyl - dimethyl silyl éther derivative they 
developed a sensitive method for the measurement 
of testosterone in plasma. However at this time 
these derivatives were not readily available 
in very pure form and were very easily hydrolysed.
Aldosterone Y -lactone, Rapp and Eik-Nes (1965) 
reported that aldosterone ^ -lactone was electron 
capturing and used this derivative for the 
measurement of aldosterone in biological samples 
(Rapp and Eik-^es, I966). However, the method 
was not sensitive enough for the measurement of 
aldosterone in small volumes of plasma (Brodie et 
al, 1967) but was suitable for the measurement 
of aldosterone in urine.
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Heptafliaorobutyrateso Improved sensitivity was 
achieved by the introduction of heptafluorobutyrate 
derivatives (Clark and Wotiz, I9 6 3; Nakagawa et al, 
1966), Quantitative methods of preparing these 
derivatives for many steroid were developed by 
‘Exley and Chamberlain (1967) and molar responses to 
electron capture detection and retention data on 
GLC were tabulated for many corticosteroid-3-enyl 
heptafluorobutyrates (Exley and Chamberlain, 1967; 
Chamberlain, 1967). These derivatives were also 
prepared in micro-quantities and characterised 
physieo-chemically by van der Molen & Groen 
(1967) and Dehennin and Scholler (1969). The 
bisheptafluorobutyrates (3-enyl-2l) of most 
corticosteroids are stable to gas chromatography 
and are much more electron-capturing than the 
corresponding chloroacetates, Unfortunately, the 
bisheptafluorobutyrates are unstable on thin layer 
chromatography and sometimes on paper chromatography 
(Exley and Chamberlain, I967) and so cannot be 
purified by these means.
Despite these problems, methods have been 
developed using these derivatives for the estimation 
of plasma concentrations of testosterone (Exley 
19 6 7, 19 68; Vermeulen, 1967; van der Molen and 
Groen 1967)3 oestrogens (Wotiz et al, 1967; Charransol 
and Wotiz, 1966) and androstenedione (Kirschner
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and. Coffman I9 6 8),
Kirschner and Coffman (I9 6 8) and Sarda et al
(1968) prepared the nionoheptofluorobutyrate of 
testosterone for the measurement of the steroid in 
plasma. This derivative is stable on thin layer 
chromatography and so can be purified more easily 
than the corresponding bisheptafluorobutyrate but 
is less responsive to electron capture detection. 
However, these methods are much more sensitive than 
the mrthod of Brownie et al (1964) using the 
chloroacetate,
Other polyhalogenated alkyl derivatives. Kirschner 
and Taylor (I96 9) proposed two new electron 
capturing derivatives for hydroxy steroids, namely 
9-H- hexadecafluoronanoate and 11-H-eicosafluoro- 
undecanoate which were more .than twice as sensitive 
to electron capture detection than the corresponding 
monoheptafluorobutyrates. They reported methods 
for estimation of testosterone and androstenedione 
using these new (derivatives in which the minimum 
amount of steroid which was readily measured was
100 pg.
Nakagawa et al (1966) prepared the 21- 
pentadecafluoro-octanoate of testosterone and found 
it to be almost as electron capturing as the 3 enyl, 
21-bisheptafluorobutyrate.
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Oestrogen derivatives. Gas liquid chromatography 
with electron capture detection has also been 
applied to the measurement of oestrogens which are 
present in low concentration in peripheral plasma,
A number of electron capturing oestrogen derivatives 
have been prepared and used for the measurement of 
these steroids in plasma.
Wotiz et al (196?) prepared the 17- 
monohepi-afluorobutyrate derivative and showed that, 
using this derivative, the practical limit of 
sensitivity of their GLC method for estimation of 
oestrogens in plasma was 2 ng/sample, which 
limits the usefulness of this technique.
Kirschner and Taylor (1969) compared this 
derivative with the 17-monopentadecafluorooctanoate, 
17-mono-(monochloro)-acetate and 17-monoeicosa- 
fluoroundecanoate and found the latter to be the 
most sensitive derivative for electron capture 
detection,
Attal et al (1967) prepared the 3-methyl ether 
- 17 “ pentafluorophenylhydrazone of estrone and 
found it to be more sensitive than the chloroacetate 
but less than the monoheptafluorobutyrate,
'"Exley and Dutton (1969) in an attempt to 
rationalise the criteria governing response of any 
derivative to electron capture detection, prepared 
a series of 27 derivatives of oestrone and
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oestradiol and investigated their behaviour on 
' GLC with electron capture detection and their 
stability on thin layer chromatography. The 
derivative of choice, namely 17P-oestradiol - 3- 
(2-iodomethyldimethylsiloxy) propyl ether) - 17P- 
iodomethylsilylether was prepared by hydroxy- 
etherification of the phenolic hydroxyl followed 
by iodomethyldimethylsilylation. It is stable 
on thin layer chromatography and during GLC and more 
responsive to electron capture detection than the 
monoheptafluorobutyrate. This derivative proved 
suitable for measurement of 17P -oestradiol in 
plasma. This study also confirmed the initial 
finding of Lovelock (I963) and confirmed a 
previous observation that addition of more than two 
heptafluorobutyrate groups may not further enhance 
the response to electron capture detection.
Conclusion. A vast number of steroid electron 
capturing derivatives have been prepared and most 
of the reagents have now become commercially 
available. A suitable derivative of a steroid for 
GLC with electron capture detection must obviously be 
easily prepared in a quantitative,reproducible 
mariner. It must be stable during GLC and be very 
responsive to electron capture detection.
Stability on thin layer and paper chromatography is
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desirable in order that the derivative can be 
purified by these means. The choice of derivative 
must also be governed by the purpose for which 
the assay is being developed. For studies of 
urinary steroids a less sensitive,more stable 
derivative may be the rational choice because the 
steroid is present in larger amounts. Thus, 
in the estimation of urinary oestrogens, Knorr et al 
(1970) reported that the 3- methyl ether 17- 
hexadecafluoronanoate provided adequate sensitivity. 
For the measurement of very small concentrations of 
steroid in peripheral plasma as is required in this 
present study, maximum sensitivity is important.
At the time this work began the most sensitive 
derivative available for corticosteroids was the 
3-enyl, 21-bisheptafluorobutyrate. Unfortunately, 
as previously stated, this is unstable on thin 
layer chromatography and purification of the ‘
derivatives is not possible,
y
Disadvantages of the electron capture detector. The 
limit of sensitivity of election capture detection 
may depend not only on the electron capture activity 
of steroid derivatives but also on other factors such 
as column adsorption and purity of extracts, solvents 
and glassware.
61
Biological extracts which have been purified by
paper or thin layer chromatography are known to
contain impurities which may 'poison' or
'contaminate' the detector and reduce sensitivity
(Rapp and Eik-Nes, 1966). A serious drawback of,the
tritium foil detector is that the upper temperature
limit is 220^C so that superheating to remove
63impurities is not permissible as with the Ni 
detector. With both detectors, addition of an 
internal standard for gas chromatography iu essential 
in order to correct for column adsorption and changes 
in detector sensitivity (Horning and Gardiner,
19 65; Brownie et al, 1964). In this present study, 
the development of a detector by-pass valve was 
considered necessary in order to prevent 
contamination of the detector.
Measurement of DOC by GLC. Studies of DOC by GLC 
are few. Using the 21-acetate derivatives of DOC, 
which is electron capturing, Rapp and Eik-Nes (1966) 
measured venous plasma concentrations of this 
steroid in rabbits. The sensitivity of this method 
(20 ng per sample) was not adequate for detection and 
estimation of this steroid in human peripheral 
plasma.
The retention characteristics of deoxy­
corticosterone bisheptafluorobutyrate on a number of
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stationary phases have been tabulated (Exley, 1967; 
Exley and Chamberlain, 1967; Chamberlain, I9 6 7) 
and the molar response to electron capture detection 
indicates that this derivative would provide 
adequate sensitivity for estimation of this steroid 
in peripheral plasma.
Use of 3-enyl, 21-bisheptafluorobutyrate. The
following section describes the development and 
assessment of a method for measurement of ^ plasma DOC 
concentration by GLC with electron capture 
detection using the 3-enyl, 21-bisheptafluorobutyrate 
derivative of DOC.
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4. MST.KODS USED IN THE PRESENT STUDY
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4. METHODS USED IN THE PRESENT STUDY
4,1. Measurement of plasma DOC concentration by 
gas chromatography with electron capture 
detection.
This section describes the development and 
assessment of a method for measurement of peripheral 
plasma DOC concentration using gas liquid 
chromatography with electron capture detention of the 
bis HFijf derivative of DOC.
4.1.2. Materials
Solvents. Dichloromethane, ethanol and petroleum 
ether (80 - 100°) (B.D.H. Ltd.) were redistilled 
immediately prior to use. Toluene (B.D.H. Ltd.) 
was reagent grade. All other solvents (acetone, 
benzene, ethyl acetate, hexane, methanol) were 
Nanograde quality solvents (Mallinkrodt Chemical 
Works, St. Louis), Glass distilled water was used 
throughout.
Standard steroids. Aldosterone (Ciba Ltd.), 18- 
hydroxy-deoxycorticosterone (Searle, Mexico, Ltd/), 
corticosterone, cortisol, DOC, deoxycortisol, 
progesterone and testosterone (CIBA Ltd.) were 
examined for purity on thin layer chromatography 
on systems 1 and 2 (see below). (^H)- DOC, (^H)-
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aldosterone (30 and 25 Ci/mM., New England Nuclear 
Corp.) and (^^C) - DOC (Radio-chemical Centre) 
were diluted in dry benzene and stored at 4°C. The 
(^H)-steroids were purified on paper chromatography 
(Bush B3) immediately prior to use.
Reagents. Heptafluorobutyrlc anhydride. (HPBA) was 
prepared as described by Exley and Chamberlain 
(1967) and stored at 4°C in glass ampoules each 
containing 0.5 ml. Acetic anhydride and pyridine 
(B.D.H. Ltd., Analar grade) were refluxed over 
calcium carbide and potassium hydroxide respectively 
and then redistilled before storage in glass 
ampoules at 4°C. Sodium hydroxide, hydrochloric 
acid, sodium bicarbonate (B.D.H. Ltd.) were reagent 
grade and sodium carbonate (B.D.H. Ltd.) was 
analytical grade.
Scintillation Mixtures. 1. Diphenyloxazol (PPG, 
10 g.) and methanol (40 ml) in toluene (2 1.) was 
used for liquid scintillation counting of aqueous 
solutions.
2, p-Terphenyl (6 g.) and dimethyl - POPOP (1,
4 - bis- 2-(4-methyl-5-phenyloxazolyl) benzene,
80 mg.) in toluene (2 1.) was used for liquid 
scintillation counting of non-aqueous solutions.
These scintillation mixtures were stored in the 
dark at room temperature.
6 6
Chromatographic Media.
Thin layer chromatography.
System 1» Silica gel (MNG/XJV 254; Macherey - Nagel, 
Ltd.) was used to prepare t.l.c. plates (250 yam) 
which were prerun in methanol before use.
Steroids were chromatographed in a mixture of hexane 
and acetone (3:1, v/v). RP values for standard 
steroids are shown in Table 2.
System 2. Glass fibre paper impregnated with 
silica gel (20 x 20 cm: I.T.L.C. Type SAP; Gelman 
Instrument Co.) were also prerun in methanol.
Steroids were chromatographed in the system described 
above. RF values for steroids are shoivn in Table 
3*
Paper chromatography. Chromato'graphy paper (no. 1 
Whatman Ltd.) was washed for 24 hours with methanol 
in a Soxhlet reflux condenser before use.
Steroids were chromatographed in Bush B3 system 
(petroleum ether(80 - 100°): benzene: methanol:
Water: 330: 170: 400: 100, v) for 6 hours. Rp 
values for standard steroids are shown in Table 4.
Glassware. All glassware was steeped in 
detergent (Deoon 75, Pharmaceutical Developments 
Ltd.) for several hours and then rinsed with water
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STEROID Rp
DOCA 0.25
PROGESTERONE 0.40
TESTOSTERONE ACETATE 0.43
TABLE 2.
Rp values of standard steroids used in T.L.C 
system 1.
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STEROID
DOC 0,35
PROGESTERONE 0.80
-
TESTOSTERONE 0.40
TABLE 3.
Rp values of standard steroids used in 
chromatography system 2 (T.L.C.).
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STEROID Rp
CORTISOL O.OI
ALDOSTERONE 0.025
CORTICOSTERONE 0.09
DEOXYCORTISOL 0.125
TESTOSTERONE 0.48
DOC 0.59
PROGESTERONE 0.90
I8-HYDÏÏ0XY-D0C 0.06
18 HYDROXY 0.04
CORTICOSTERONE  ^ ^
TABLE 4.
RF values of standard corticosteroids on paper 
chromatography in Bush B3 system.
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followed by methanol. Test tubes were silanised 
(Repelcote, Hopkin and Williams, Ltd.) and then 
rinsed with benzene immediately before use.
Gas-liquid chromatography. A Pye 104 model 84
gas-liquid chromatography (Pye Unicam, Ltd.)
63was used equipped with a Ni electron source 
and a Rikadenki recorder (Model B24, Rikadenki 
Kogyo Co. Ltd.) Pyrex glass columns (1.5 m x 4 mm.) 
were silanised and packed with 100 - 120 
Supelcoport coated with 1% OVl (Supelco, Inc.) 
Conditions were as follows
Temperatures
Column : 205°C
Flash heater : 250°C
Detector^ ; 250°C
Nitrogen Flow
Carrier gas : 40 ml/minute
Quench gas r" : 20 ml/minute
Electron Capture Supply
Pulse space : 150 us.
Pulse width : 0.75 - 0.25 us.
Pulse amplitude: 47 - 60 V positive.
High purity nitrogen ( < 7 p.p.m. oxygen, Air Products, 
Ltd.) was passed through molecular sieves which 
were reactivated weekly.
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Gas liquid chromatograph detector by-pass . 
valve (Fig. 2). This valve was designed and 
constructed in our department for use with the 
Pye 104 chromatograph. The by -pass valve was 
constructed from polytetrafluoreothylene (P.T.F.E.), 
With this device it was possible to select 
column effluent fractions for passage through the 
detector. For the first 4 minutes after sample 
injection nitrogen from the reference column 
was passed through the detector while the sample 
column eluate, found in preliminary experiments 
to contaminate the detector, was passed to waste*
The remainder of the sample column eluate was then 
passed through the detector by altering the 
position of the valve plunger. In this way, 
contamination of the detector and subsequent loss 
of sensitivity were avoided. Since the introduction 
of the initial valve, other models of valves have 
become oommerciaHly available and a rotary action 
valve also constructed of P.T.F.E, (Carle valves, 
Inc.) has now replaced the original cylindrical 
valve,
Gas"^  chromatograph - mass spectrometry (G.C.M.S.).
G.C.M.S. analysis was carried out using anL.K.B.
9000 spectrometer under the following 
conditions ;-
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wastû
A
A
column 1
ecd
A wasteA
r
X X X  ■ ■ J
7^4plunger
column 2
Figure 2.
Detector 'by-pass valve used as a means of preventing 
detector contamination. This valve was constructed 
in poly-tetro-fluoroethylene (PTPE).
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Ionising voltage
Ion source temperature
Molecule Separator temperature
Scan period
Oven temperature
Column (G.L.G.)
70 e.V.
250°C
250°C
0.5 seconds 
200°C 
OVl
These analyses were performed by Dr. C.J,W. 
Brooks, Chemistry Department, Glasgow University.
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4.1.2. PROCEDURE
Plasma. Blood samples were taken into lithium 
heparin (lOOO i.u.) and the separated plasma ( 5- 25 
ml.) was stored at -20^C until required for assay.
Extraction. Plasma (5 - 25 ml.) to which 
deoxycorticosterone (5000 cpm) had "been added was 
extracted with dichloromethane (10 vol.) and the 
extract was washed consecutively with sodium 
hydroxide (O.IM aqueous), acetic acid (O.l M, 
aqueous), and water (l vol. each.). Th^ washed 
neutral extract was then evaporated to dryness in 
a rotary evaporator and transferred in 
dichloromethane (5 x 5 ml.) to a stoppered conical 
test-tuhe, the solvent being evaporated to 
dryness under a stream of nitrogen.
Purification. Two raethocis of measurement of plasma- 
DOC concentration by gas chromatography were tested, 
the second being an attempt to simplify and 
improve the first.
Method 1. The dry residue was treated overnight 
with pyridine (0,05 ml) and acetic anhydride (0.05 
ml.) at 35^0. The excess reagents were then 
removed in vacuo and the residue was chromatographed 
in system 1 with 20 pg, each of progesterone and 
the acetates of DOC and testosterone on adjacent
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lanes separated by a trough. The standards were 
located in u.v, light (220 - 230 nn.).
The region of the plasma extract lane 
corresponding to the DOC acetate standard was 
removed and eluted with methanol ( 3 x 3  ml) 
which was then evaporated under a stream of nitrogen 
at approximately 35^0. To the residue was 
added 0.1 ml saturated methanolic sodium carbonate 
and the mixture left at room temperature overnight 
to hydrolyse the steroid acetate. The methanol was 
evaporated and the residue chromatographed in system 
2, In this case, 20 ug. DOC was used as standard.
The DOC region was located and eluted dropwise with 
methanol (l ml.) and a sample (O.l ml) was taken 
for counting of H in a liquid scintillation 
spectrometer (34^ efficiency) using scintillation 
mixture 2* The remainder was evaporated to 
dryness and dissolved in 100 ul. benzene preparatory 
to g.l.c.
Method 2. The dry residue from the neutral plasma 
extract was partitioned between ^0% aqueous methanol 
(2 ml) and n-hexane (2 ml.) and the hexane layer 
was discarded. The methanol was evaporated to dryness 
under a stream of nitrogen and the residue was 
chromatographed on paper in Bush B3 system with 
standards of DOC, testosterone and 
progesterone ( 20 ug. each) in
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adjacent separated lanes. The standard steroids 
were located in u.v. light (220 - 230 nm.) and the 
region corresponding to DOC in the sample lanes 
was eluted dropwise with methanol (1 ml). The 
methanol eluate was treated as described under 
method 1,
Gas-liquid chromatography
Preparation of standard heptafluorobutyrates. 10 ng,
of steroid was dissolved in benzene ( 10 ul") 
heptafluorobutyric anhydride (10 ul) was added and 
the mixture was incubated at 60^0 for 30 minutes. 
Excess reagents were removed at 60^C under a stream 
of nitrogen. Conversion was in excess of 98^ (see 
later). The residue was dissolved in benzene and 
dilutions ranging from 25 - 500 pg/ul were made.
Plasma extracts. KFBA (10 ul) was added to the 
purified plasma extract and the mixture incubated 
at 60°C for 30 mi&Mtes. Excess reagents were 
removed as previously described and progesterone 
EFB (500 pg) in benzene (50 ul) was added to the 
sample. Between 1 and 25^ of the total extract 
waS' applied to the g.l.c. column.
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4.1.3. RESULTS
Characterisation of the plasma deoxycorticosterone 
derivative. Partial characterisation of the plasma 
deoxycorticosterone derivative was obtained by 
comparing some of its physical properties with 
those of the authentic derivative prepared 
according to the method of Dehennin and Scholler
(1969) and recrystallised twice from methanol.
(a) Gas-liquid chromatography. In both cases a 
single major peak was obtained with g. 1 .'c. together 
with two minor peaks accounting' for less than
Ifo of the total peak area. Retention times of the 
authentic material and the plasma product were 
identical on different g.l.c. columns OVl, 19 
min; i;g 0V17, 9.4 min; 1^ QPl, 22 min; Ifo OV 25, 6 
rain; 1$^ OV 225, 10 rains.). Gas liquid chromatography 
of mixtures of plasma product and authentic compound 
gave no indication of differences in chromatographic 
properties.
(b) Mass spectroscopic analysis. Results of 
mass spectroscopic analysis of the gJ.c. effluent 
suggested that the plasma product was identical to 
the authentic deoxycorticosterone HPB (Pig. 3). Both 
preparations showed relatively little fragmentation. 
The ion of highest mass in both spectra
was 7 2 2; corresponding to the molecular ion
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Figure 3.
Mass spectrograph of authentic DOC his HFB and 
plasma product on estérification. The upper 
diagram shows the fragmentation pattern of the 
plasma extract and the lower the authentic steroid 
derivative. " „
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of deoxycorticosterone HPB, The retention index 
value (Kovats 1958) was 2778 in each case.
The two minor peaks observed on g.l.c, showed 
apparent molecular ions at m/e 46$ and $68.
Removal of endogenous plasma progesterone. Since 
progesterone HPB was used as an internal standard 
for g.l.c. it was necessary to show that all 
endogenous plasma progesterone was removed during 
chromatographic purification. On no occasion when 
random plasma extracts were analysed without 
addition of the internal standard was there a 
perceptible g.l.c. peak in the progesterone HFB region. 
Further confirmation was obtained by adding $0 ug. 
progesterone to each of five normal plasma samples 
before extraction and purification by methods 1 and 
2. Again no evidence of progesterone contamination 
was present on g.l.c.
Efficiency of estérification with HPBA. Deoxycortico­
sterone ($ ug.)^was treated with HFBA using the 
proportions and conditions employed in the method 
described previously for measuring deoxycorticosterone 
in plasma. The product was analysed using g.l.c. with 
flame ionisation detection in order to demonstrate 
the presence or absence of residual 
deoxycorticosterone. With the exception of two 
minor peaks mentioned above, neither of which 
corresponded to deoxycorticosterone, a single peak
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corresponding to that of DOC HFB was obtained.
In a further experiment, deoxycorticosterone 
3(5 ug.) containing K-deoxycorticosterone (10,000 
c.p.m.) was esterified as described previously and 
the product chromatographed in system 2. The 
region corresponding to deoxycorticosterone was 
eluted but contained no radioactivity, suggesting 
that estérification was quantitative. However, 
only 51^ of the activity was found in the 
deoxycorticosterone region, the remainder occurring 
between deoxycorticosterone and deoxycorticosterone 
HFB. This was possibly due to partial 
decomposition of deoxycorticosterone HPB,
Finally, three samples of deoxycorticosterone 
(1500 c.p.m.) were esterified and the products 
chromatographed on paper (cyclohexane: deoxan; 
methanol; water; 4:4: 2: 1, by vol.)
Recovery of H from the DOC HFB region 
ranged from 98,5 to 99.3 (mean 98.9)und from the 
deoxycorticosterone region 0.7^ to 2.5^ (mean 
1.1 )^.
Efficiency of the detector by-pass valve. Aliquots 
of esterified plasma extract were submitted to 
gl;c. with and without the valve in circuit. Traces 
obtained without the valve were unsuitable for 
measurement due to detector contamination, loss of
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sensitivity and peak distortion whereas those 
obtained with the valve presented no such 
problems (Pig.4).
No broadening or tailing of peaks was 
observed when, the valve was in use. Standard 
deoxycorticosterone HPB samples (5 to 200 pg) 
applied to the column with and without the valve 
in circuit gave identical peak areas indicating 
that no leakage or decomposition of samples was 
occurring in the valve,
Standard curve. The heptafluorobutyrates of 
deoxycorticosterone and progesterone had retention 
times of 19 and 11 minutes respectively, under
the conditions employed. Calibration curve, were
obtained from duplicate estimations of
deoxycorticosterone-HPB within the range 25-200 pg,
2The peak areas in mm from 10 consecutive standard 
curves, expressed as means - S.D, were $6.5 - 2.5,
1 1 7 .6 i 7.7, 218,0 - 8.2, 326, 1 - 7.1, 438.1 -
8.2 for 2 5 , 50, 100, 150 and 200 pg of 
deoxycorticosterone respectively. For these data, 
a linear regression line, y - 6,48 + 2,13 x was 
obtained and a correlation coefficient (r) of 1.00,
The peak area of each sample was expressed relative 
to the peak area of the internal standard
(progesterone-HPB). The calculated concentrations of DOC were
NORMAL PLASMA EXTRACTS ON GLC
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F i g u r e  4
GLC traces of normal plasma extract applied to 
colujan with and without valve in circuit.
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3
corrected for losses from the recovery of H- 
deoxycorticosterone.
Blanks.
Water. Two samples of water were assayed with each 
hatch of plasma samples. On no occasion was any 
peak corresponding to DOC-IIFB detected in these 
samples although peaks corresponding in position 
to testosterone HPB were found when the valve was 
not employed.
Plasma. No DOC-HPB could he detected in two 
25 ml, samples of plasma from a bilaterally 
adrenalectomised patient maintained on cortisol 
and 9#^fluorocortisol.
3
Yield of H deoxycorticosterone.
Method 1, The mean (- S.D.) recovery of (^ h) 
deoxycorticosterone after purification (method l) 
was 4 1 .5 6 - 16.04 (n = 226). The mean recovery 
of ( H)-deoxycorticosterone after each stage of 
purification is shown in Table 5.
. 3
Method 2. The mean (- S.D.) recovery of ( h )
deoxycorticosterone after purification (method 2)
was 68 ,4 5 - 14 .6 2 (n - 2 0 0).
3The me an recovery of E - deoxycorticosterone 
after each stage of purification is shoim in Table 
6.
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Stage of purification Mean Recovery 
of
(^h ) doc
n
Extraction, washing 99.5% 8
Acelylation, t.l.c.
1, elution 85.5% 8
Hydrolysis, t.l.c.
2, elution 66.9% 8
TABLE 5.
Mean recovery of ( H) deoxycorticosterone after
each stage of purification method 1
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Stage of purification | Mean total 
Recovery 
(%) DOC
n
Extraction, washing 9k.0% 10
Partition 90.6% 10
Paper chromatography,
elution
1 ... -- -- - -
75.k% 10
TABLE 60
Mean recovery of ( H) deoxycorticosterone after each
stage of purification method 2 ,
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Recovery of exogenous unlabelled DOC. After
addition of 5, 10, 20 ng. deoxycorticosterone to 
sample (25 ml. each) of a normal plasma pool the 
means of duplicate recoveries (method 1) were 
93^, 100^, 92fo and 9hfo recpectively.
Precision and sensitivity.
Method lo Replicate analysis was carried out on 
plasma (25 ml, each) from four different pools 
of normal plasma. These gave mean (t S.D.) 
concentrations of DOC (in ng/100 ml) as follows:-
pool (i) 18.1 - 2.32 (n = 7) , 12.7 (CV)
pool (11) 15.0 - 3.16 (n = 8) , 21.0 (CV)
pool (111) 6.7 - 1.08 ( n =7) , l6.1 (CV)
pool (Iv) 10.2 ± 1.18 (n = 10) , 1.0 (CV)
(CV “ coefficient of variation)
Precision at lower concentration was determined 
using a plasma pool from a normal subject treated 
with dexamethasone. In this case, plasma 
concentration was 5.28 - 0,03 ng/lOO ml (n = ?).
Using the standard deviation of the mean of this 
pool the sensitivity for single estimations 
calculated from the formula  ^  ^ (see Braunsberg
and James, I9 6 1) was 0.5 ng/lOO ml. (p = O.O5 , 
max index of precision = 10^ n = 1 where t is a 
critical value of students t,s an estimate of the 
standard deviation near the limit of sensitivity of
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the method, and n the number of replicate 
determinations). Linearity of response as compared 
with the calibration curve was also tested by 
analysing in duplicate different volumes of plasma 
pool. The mean content in ng of 5? 10, 15 and 25 
ml. of plasma were 0.24, 0.6?, 0,90, 1,75. For 
these data a linear regression equation y = 0 .095% - 
0,03 was obtained with a correlation coefficient 
(r) of 0.93* Between batch variation was determined 
by duplicate analyses included in five different 
assays. These gave a mean concentration (- S.D.) 
of 10.2 t 1.8 ng/100 ml.
Method 2. Replicate analyses were carried out on 
plasma (10 ml. each) from three different pools of 
normal plasma. These gave mean (- S.D.) concentrations 
of deoxycorticosterone (ng/100 pi) of 7*5 - 0.44 
(u = 5), 10.0 - 1.21 (n = 12) and 11.3 - 1.39 (n = 5). 
Linearity of response as compared to the calibration 
curve was tested by analysing in triplicate 
different volumes of plasma pool. The mean content of DOC 
in ng, of 5s 10 and 20 ml of plasma were 0.5»
0.98, 1.95 (r = l.O) respectively. For these 
data a linear regression equation y = 0.097% ^
0,015 was obtained. Between batch variation was 
determined by duplicate analyses included in 
twelve different assays. These gave a mean DOG 
concentration (i S.D.) of 10.0 - 1.54 ng/lOO ml.
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Eleven samples were analysed using both 
methods (l and 2) of purification and the results 
were correlated (Fig. 5). For these data a 
linear equation y = 0 .0 6 8 -i- 0.91% was obtained 
and a correlation coefficient (r) of 0.976.
The specificity of the method was further 
examined by comparison of results obtained on the 
same sample analysed by gas-chromatography (method 
l) and radioimmunoassay (James et al, 1971). For 
these data a linear regression equation y 2,7 + 
0 . 8 1 6 x  was obtained with a correlation coefficient 
(r) of 0.872 (Fig. 6).
Normal range. Samples from 30 normal ambulant 
subjects aged between 20 and 40 years (25 male,
5 female) were taken between 10,00 h and 11.00 h. 
None of the females was pregnant or taking oral 
contraceptives. Concentrations range from 4.1 to 
13,2 ng/100 ml with a mean of 8.7 ng/100 ml (see 
Table 20). Details of this method with studies 
of its reliability have been published (Wilson.and 
Fraser, 1971).
20'
Method 2 
ng /lO O m
15'
h
y =0-063 "Î-0-31X
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FiaiJiiK 5,
Correlation of plasma DOC concentration measured by 
GLC methods 1 and 2. These data gave a regression 
y = 0.068 +0.91 x with a coefficient of'correlation 
(r) of 0 .9 7 6,
GLC METHOD
DOG ng/100 ml
20 ’
0.8l6x
10
252015105
llIA METHOD 
DOC ng/100 ml
Figure 6. Correlation of plasma DOC concentrations 
measured by GLC (method l) and radioimmunoassay (James 
et alj 1971)* Radioimmunoassay was kindly carried out by 
Professor V.H.T, James of St. Mary's Medical School.
For these data a regression equation y = 2.7 +0.816 s with 
a coefficient of correlation (r) of 0.872^ was obtained.
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4.2. Measurement of plasma DOG concentration by 
radioimmunoassay.
This section of the thesis describes 
the development and assessment of a method for 
measurement of plasma DOC concentration using 
antiserum raised to DOC, Methods of preparation 
of immunogens, immunisation programmes, testing 
of antisera, are described.
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4,2,1. Additional Materials required, for 
radloi nmmno assay.
Solvents. Dioxan and ethylene glycol (B.D.H. Ltd) 
were reagent grade and analytical grade respectively.
Reagents. Boric acid, succinic anhydride, gelatin, 
tri-n-hutylamine and isohutylchlorocarhonate (B.D.H., 
Ltd.) were reagent grade. Dextran T-SO (Pharmacia 
Ltd), o-carhoxymethyloxlme hemihydrochloride 
(Aldrich Chem. Co.) were used without prior 
purification. Charcoal (Norit A, activated, B.D.H.Ltd) 
was washed with methanol and dried in a vacuum 
oven prior to use. Tris buffer (Tris-hydroxymethy1- 
methylamine: Boehringer Corp.) was used without 
purification.
Biochemicals. Bovine serum albumin (Armour 
Pharmaceuticals, Ltd),^-globulins (Cohn fraction.11, 
rabbit ond bovine) and poly-L-lysine (Mf, 175>000) 
were obtained from Sigma, Ltd, and were used without 
purification.
Nicotinamide adenine dinucleotide (reduced,
NADH2 ) and 20j^“ hydroxys teroid dehydrogenase 
solution were obtained from Boehringer Corp. and 
were not further purified prior to use. Nicotinamide 
adenine dinucleotide (NAD, Grade III) and Freund's 
complete adjuvant were obtained from Sigma, Ltd. 
and were used without purification.
93
4.2,2, Preparation of steroid protein con,jugate
(a) Preparation of
(i) Aldosterone-3 carboxyraethy- 
loxime
(ii) DOC- 3 carboxymethyloxime.
Aldosterone and deoxycorticosterone both 
possess 20 - carbonyl groups which may interfere
in the preparation of the 3- ; carboxymethyloxime.
In order to prepare specifically the 3-oxime and 
prevent the formation of any 3, 20-dioxime, the 20- 
carbonyl group was protected by enzymic reduction 
to the 20^- hydroxy group. After formation of 
the 3-oxime the 20c^- hydroxy group was oxidised 
enzymatically to the 20 - carbonyl group. Using
this 3-stage method (a ), standard 3 - carboxy- 
raethyloxiraes of aldosterone and DOC were 
prepared and used to monitor the direct preparation 
of these oximes from the free steroids by method (b ).
Method A .
(i) Reduchon of 20 carbonyl group. The free 
steroid (20 x 200 ug.) containing (^H)- labelled 
steroid (100,000 cpm) was dissolved in tris buffer 
(1.8 ml., O.IM, pH 7.3) and NADH2 solution (10 ul.
5 mg/ml. tris buffer pH 8 .0 ) and 2oj^-hydroxysteroid 
dehydrogenase (3 ul., 1 mg/ml, aqueous) were 
added (Henning and Zander, 1962).
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After incubation at 37^C for 48 hours, glass 
distilled water (l ml.) was added and the 
mixture was extracted with ethyl acetate (  ^x 3^^). 
The combined extracts were evaporated to dryness 
under a stream of nitrogen and then applied in 
dichloromethane to an I,T.L.C. plate with standard 
DOC and aldosterone in adjacent lanes. The 
plate was developed in a hexane/acetone mixture 
(3:1, v/v for 1 hour),
values for DOG, aldosterone and their 
corresponding 20 ^ - hydroxy derivatives were 
0.53, 0.20, 0.40, 0.08 respectively. The areas 
corresponding to the 20 ^  - hydroxy derivatives 
were dropwise eluted with methanol. The yields 
of aldosterone and DOC derivatives were 25^ 
and 31/^û respectively.
(ii) Formation of 3-carboxymethyloxime .
derivative. '20 -hydroxy steroid'
(0,5 mg) was refluxed for 1 hour with o-carboxy­
me thylamine hemi-hydrochloride (4 mg.) in a 
solution of sodium hydroxide (0.4 ml., 5^ aqueous) 
and ethanol (5 ml). On cooling the mixture was 
adjusted to pH 6 with hydrochloric acid (0.5 M) 
and the ethanol -was then removed under a stream of 
nitrogen. After addition of water (10 ml.) the 
mixture was re-adjusted to pH 10 with sodium 
hydroxide solution (O.IM) and extracted with 
dichloromethane (20 ml) and the extract was discarded. 
The solution was adjusted finally to pII2 with
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hydrochloric acid (0.5M) and extracted with
dichloromethane (3 x 25 ml,).
The extract was evaporated to a small volume 
and applied to an ITLC plate which was developed 
in hexane-acetone mixture (3:1, v/v) for 1,5 
hours Rp values were recorded as follows.
Rp
DOC 0.58
' 20-dihydro -DOC' ' 0.40
20-dihydro DOC’-3 carboxymethyloxime 0,05
aldosterone ’ 0,30
/
20-dihydro aldosterone 0.10
 ^ t /
20-dihydroaldosterone - 3
carboxymethyloxime 0,02
The area corresponding to the carboxy­
me thyloxime derivatives were eluted with methanol 
(5 ml.). Yields of the DOC and aldosterone 
derivatives were 75/j and 6l^ respectively,
(iii). Oxidation of 2Q|^-hydroxy group. *20<^- 
hydroxysteroid* - 3 carboxymethyloxime (10 x 30 ug) 
was dissolved in tris buffer (1,8 ml., O.IM, pH.
7 .3) and NAD solution (lO ul, 5 mg/ml. tris buffer 
pH 8 .0 ) and 20(^hydroxysteroid dehydrogenase 
solution (5 ul.jl mg/ml).were added. The solution 
was incubated at 37^C for 48 hours and was then 
extracted with dichloromethane and chromatographed 
as described in section 1 of method A. Rp values were
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recorded as follows:-
Rp
DOC 0.58
20-dihydro DOC* 3-carhoxyinethy­
loxime  ^ 0.05
DOC-3-carhoxymethyloxime 0.2
Aldosterone 0.30
20Ldihydroaidesterone-3“
carboxymethyloxime 0,02
Aldosterone-3 carboxymethy]oxime 0.10
Yields of DOC and aldosterone 3" 
carboxymethyloxirae derivatives were 65^ and 60  ^
respectively. Overall yields of these two 
derivatives were 15.1^ and 9.1^ respectively.
Method B, .
Direct preparation of (i) DOC-3-carboxymethyloxime 
v" (ii) Aldosterone-3-carboxy-
methyloxime
Free steroid (100 ng.) containing (^H)-labelled 
steroid (100,000 cpm) was refluxed with o-carboxymethyl­
oxime hemihydrochloride (40 mg.) in sodium 
bicarbonate solution (1 ml., 0.2 M) and ethanol 
(20 ml) for 10 minutes. On cooling the carlboxymethyloxime
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derivative was extracted as described In method A, ii 
The extract was evaporated to a small volume 
and applied in methylene chloride to an ÏTLC, 
plate which was developed in hexane-acetone mixture 
(3:1, v/v) for 1,5 hours. By comparison with 
standards (prepared in method A) run in adjacent 
lanes the steroid 3-carboxymethyloxime derivatives 
were detected and eluted with methanol. Yields 
of the 3-carboxymethyloxime derivatives of DOC 
and aldosterone were 65^ and respectively.
Preparation of (a) DOC-3-albumin conjugate
(b) Aldosterone-3-albumin conjugate
(c) Aldosterone-3-poly-l- 
lysine conjugate.
Method . Steroid“3”Carboxyraethyloxime (100 mg) 
and tri-n-butylamine (0,05 ml) were dissolved in 
dioxane (4 ml) and after cooling to 10^0 
isobutylchlorocarbonate (0,3 ml) was added. The 
reaction was allowed to proceed for 20 minutes after 
which the mixture was added in one portion to a well 
stirred, cooled solution of protein (bovine serum 
albumin, 0,4 g, or poly-L-lysine, 0.3 g) in 
water-dioxane mixture (1:1, v/v; 15 ml), containing 
sodium hydroxide (0.3 ml., ÏM aqueous).
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A further 0,1 ml sodium hydroxide solution was 
added after 15 minutes in order to adjust the 
solution to pH 8,5. Stirring and cooling were 
continued for a further 4 hours and then the 
solution was dialysed overnight against distilled 
water (10 1,).
The mixture was adjusted to pH 4,5 with hydro­
chloric acid (O.l M) to precipitate the conjugate which 
after storage overnight at 4^0 was collected by 
centrifugation, ^
The precipitate was redissolved in water 
(5 ml,) by adjusting to pH 5.5 with sodium 
hydroxide (0,1M) and then re-precipitated by 
addition of acetone and adjusting to pH 5.0 with 
hydrochloric acid (O.IM), The conjugate was 
again collected by centrifugation and finally 
lyophilised.
Preparation of deoxycorticosterone 21 hemlsucclnate, A 
solution of deoxycorticosterone (lOO mg.) containing
"I
1 0 , 0 0 0  cpm ( h ) deoxycorticosterone and succinic 
anhydride (lOO mg.) and dry pyridine (5 ml) was refluxed 
for 4 hours. The reaction mixture was evaporated 
to^dryness under reduced pressure and the semi­
solid residue was dissolved in chloroform, washed 
three times with water, dried over sodium 
sulphate and then evaporated to dryness under a 
stream of nitrogen. The residue was recrystallised
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twice from acetone. The yield of deoxycorticosterone 
21~hemisnccinate was 81^ (103 mg.)
Preparation of deoxycorticosterone - 21 albumin conjugate.(d)
Deoxycorticosterone-21 hemisuccinate (100 mg,) and
tri-n-butylamine (0.05 ml.) were dissolved in dioxane
(4 ml.) and after cooling the solution to 10°C
isobutylchlorocarbonate (.03 ml.) was added. The
reaction was allowed to proceed for 20 minutes at
4^C after which the solution was added in ^ one portion
to a well stirred cooled solution of bovine serum
albumin (0.4 g,) in 1:1 water dioxane (15 ml.) and
sodium hydroxide (0.3 ml., IM). A further 0.1 ml,
of sodium hydroxide was added after 15 mins. to
adjust pH from 6,8 to 8,5. Stirring and cooling
were continued for 4 hours. The solution was
dialysed overnight against glass distilled water (10 1)
after which the mixture was adjusted to pH 4.5
with hydrochloric acid (IM)*. The product precipitated
oand after storage at 4 C overnight was collected 
by centrifugation. The precipitate was redissolved 
in water (5 ml.) by adjusting to pH 5.5 with 
sodium hydroxide (O.l.M), The conjugate was 
reprocipitated by addition of acetone (4 ml,), 
adjusting to pK 5.0 with hydrochloric acid (O.IM), 
and collected by centrifugation subsequently to be 
lyophilised. The yield of the reactions are shomi in
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Table 7. The number of steroid residues per
protein molecule was calculated from the yield of
%
the reaction and the recovery of ( Il)-steroid and 
the results are shown in Table 7«
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b. c. d.
3
$ Yield ( h)- steroid 48 51 31 45
Moles steroid in conjugate 109 137 55 105
Yield conjugate (mg) 370 391 250 310
Moles protein in conjugate 
X lO"^
4.43 4,72 1.3 3.75
Steroid molecules per 
protein molecule
24.6 2 9 .0 26 .1 28.3
TABLE 7
Preparation of steroid protein conjugates.
Yield of reaction and number of steroid residues 
per protein molecule.
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4.2,3. Programme for immunisation and antibody 
titration.
Rabbits, 24 male New Zealand Milte rabbits (^oight
approximately 3 Kg) were used for this study,
1 mg. of steroid protein conjugate in aqueous 
suspension (0,5 ml.), was emulsified with Freund's 
complete Adjuvant (0,5 ml.) and injected 
subcutaneously in both thighs.
Booster injections were given in the same way , 
monthly,for a period of five months followed by a 
3 month rest after which booster injections were 
continued monthly. One week after the third 
and all subsequent injections, a blood sample (5 ml.) 
was taken from the middle ear vein and the serum, 
stored for antibody titration studies,
Guinea pigs. 12 male Duncan Hartley guinea pigs 
were used for this study.
0,5 mg, of steroid-protein conjugate in 
aqueous suspension (0.25 ml.) emulsified with 
Freunds complete Adjuvant was injected subcutaneously 
in both thighs. Booster injections were given 
after 1, 2 and 3 months, then the animals were 
exsanguinated I week later by cannulating the 
carotid artery. Serum was stored for antibody 
titration studies.
The immunogen used for each rabbit and guinea 
pig is shown in Table 8,
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imiUNOGEN RABBIT NO. GUINEA PIG 
NO.
DOC - 3- 1 - 10 1 - 3
ALBÜMIN
DOC- 20- 11 - 15 4 - 6
ALBTOIN
ALDOSTERONE-
3- ALBUMIN
16 - 21 7 - 9
ALDOSTERONE -
3- POLY-L-
22 - 24 10 - 12
LYSXNE
TABLE 8
Imiiiunogen used for each rabbit and guinea pig*
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4,2,4. Assessment of Antisera,
Antisorum dilution curves. The presence of 
antibodies in each antiserum was demonstrated by 
preparing antiserum dilution curves.
Dilution and incubation. Doubling dilutions of 
each antiserum were prepared in O.IM borate 
buffer pH 8,0, containing 5^ methanol and 
gelatin. 0,5 ml. of each antiserum dilution was 
added in duplicate to glass test-tubes (2^5 ml)
'Z
containing ( H)-steroid (2000 cpm). The tubes were 
well mixed then incubated at room temperature for 
3 hours then at 4^C in an ice bath for 1 hour.
Separation of bound and free fractions, 0,5 ml,
dextran coated charcoal suspension (1:6) was added
to each sample which was well mixed and allowed to
stand for 5 minutes before centrifuging at 4^ -C at
2,500 rpm. for 10 minutes, 0.5ml. of the supernatant
/ 3 \liquid which contained the bound ( H)-steroid
3was removed for estimation of H by liquid 
scintillation counting. Per cent bound(/p^steroid 
was plotted against antiserum dilution (see Table 
9)7
standard Curves. Standard curves were prepared for 
antiserum at dilutions at which 50 - 60^ of H- 
steroid was bound, ,
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RABBIT NO IMT'IUNOGEN DILUTION AT M U C H  50fo 
(^H) - DOC WAS BOUim
1
2
3
4
5
6
7.
8
9
10
11
12
13
14
15
16
17
18
19
20 
21
22
23
24
DOC - 3" 
Albumin
DOC - 21- 
albumin
Aldosterone 
3 - albumin
Aldosterone
3-poly-l-
lysine
Normal Rabbit 
Serum.
1:850
1:10
1:700
1:800
1:5
1:5
1:5
1:6
1:50
lr5
1:8
1:30
1:5
1:60
1:200
1:9
TABLE 9
Dilution of antisera required for 50^ 5 binding 
of (^h ) - steroid. Rabbit - 3 immunisations.
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Incubation. 0.5 ml. anti serum, appropriately 
diluted in borate buffer (0.1M,pH 8, 5/ methanol, 
0.5^ gelatin), wa.s added in triplicate to glass 
test-tubes (2.5 ml.) containing ("^li)-steroid and 
steroid (O, 6 . 2 5 ,  1 2 . 5 ,  25 ,  50, 100, 200 pg).
The tubes were well mixed and then incubated 
at room temperature for 2 hours followed by 
incubation at 4^0 in an ice bath for 1 hour.
Separation of bound and free steroid. Bound and
free steroid were separated as previously described 
using dextran-coated charcoal. Bound 
steroid was estimated by liquid scintillation 
counting.
Per cent bound ( Il)-steroid was plotted 
against pg added steroid in each sample (see Table
11).
Results of assessment of antisera. Dilution curves 
obtained with normal rabbit and guinea pig sera are 
shoivn in Tables 9 and 12.
Rabbit antisera 1 - 1 0 .  (POC) . The antibody 
titration data obtained after three immunisations 
are shown in Table 9* The improvement in antibody 
titre in rabbits 1, 5 and 4 is shown in Table 10. 
The titre in the remaining rabbits did not 
improve after subsequent immunisations and were not
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Month of 
Injections
Dilution for 50^  ^bound 
for each antiserum 1 :
(3i) -
X
steroid
1 3 4 16 20 21
3 850 700 800 300 60 200
4 1000 750 1000 1000 200 1000
5 5000 2000 2500 6000 500 1500
6 8000 3000 7500 10000 1000 2000
7 10000 7500 10000 25000 2500 2000
TABLE 10
Improvement in antibody titre in individual 
rabbits during several months of immunisation.
1 08
Antiserum Dilution
1 : X
$ bound(^H)"Steroid $ Displacement 
(^H)-steroid
0 pg 50pg 100
pg
0-10
pg
0 - 100
PS
1 8 ,0 0 0 75 47 38 7.5 37
10 ,00 0 75 40 30 10 45
12,000 63 38 29 6 34
3 5 ,0 0 0 76 57 47 8 29
7,500 56 36 28 - 6 28
4 5 ,0 00 63 43 31 5 32
7 ,5 00 52 36 26 4 26
10,000 40 26 18 4 22
16 1 ,5 00 85 68 59 5 26
2,500 64 ' 47 37 5 27
20 2,000 80 62 51 6 29
2,500 62 45 35 5 27
3 ,0 0 0 57 41 31 5 26
21 2,500 82 57 42 8 40
3,000 64 47 38 5 26
TABLE 11
Sensitivity data for steroid antisera showing dilution
of each antiserum and corresponding per cent bound (^H)
steroid. Incubation conditions and separation of bound 
and free steroid are described in section 4,2. .
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'GUINEA PIG 
NO.
IMMUNOGEN DILUTION AT 50^ 
BOUND (^H)- 
STEROID
1 DOC “ 3 - 1 :8
2 albumin 1:30
3 1:7
4 1:9
5 DOC - 21- 1:30'
6
albumin 1:6
7 - 1:8
8 Aldosterone - -
9 3- albumin 1:50
10 1:9
11 Aldosterone - 1:9
12 3- poly-l-lysine 1:5
Normal Guinea 
Pig Serum
1:40
TABLE 12.
Antibody production by guinea pigs
1 10
used for standard curves. Standard curves were 
prepared with antisera 1, 3 and 4 after 7 
immunisations and are shoim in Table 11,
Rabbit antisera 11-15 (POC). The antibody 
titration data obtained after 3 immunisations 
are shown in Table 9* No improvement was obtained 
on subsequent immunisation. No standard curves 
were prepared.
Rabbit antisera 16-21 (Aldosterone). The antibody 
titration data obtained after 3 immunisations are 
shomi in Table 9* The improvement in antibody 
titre in rabbits 16, 20 and 21 after subsequent 
immunisation is shewn in Table 10. No improvement 
in antibody titre was demonstrated with the 
.remaining rabbits which were not used for standard 
curves. Standard curves were prepared with 
antisera l6, 20 and 21 after 7 immunisations and 
are shown in Table 11,
Rabbit antiserum 22-24. Very low antibody titres 
were obtained after 3 immunisations (Table 9) and 
no improvement was demonstrated with subsequent 
immunisation. No standard curves were prepared, 
Guinea pigs, ■ Very low antibody titration curves 
were obtained with all guinea pig anti sera (Table
12).
No standard curves were prepared.
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4.2.5. MIEiSURLMENT OF PERIPHERAL PLASMA DOC 
CONCENTRATION BY RvlDIOIM^lUNQASSAY
Method
Plasma. Plasma samples were collected as described 
in section 4.1. Two ml, was used for each assay 
and each hatch of assays contained duplicate water 
' blanks (2 ml.) and control plasma samples.
Extraction and Purification. The sample to which
approximately 25,000 cpm (^H)-DOC had been added
was extracted with 10 volumes of dichloromethane
which was then washed consecutively with one
volume each of sodium hydroxide (O.IN, aqueous),
acetic acid (O.IN) and water before evaporating
to dryness. The final residue was chromatographed
on methanol-washed paper (Whatman 2) in system 1
for seven hours. The DOC region was located by
radioscanning (Panax, Ltd.) and eluted with
methanol. An aïiquot of the eluate was assessed 
3for ( H) recovery and, on this information,
•7
duplicate aliquots containing 5000 cpm ( h )"DOC 
were taken for radioimmunoassay.
Radioim'-ainoassay. Samples and duplicate (O, - 300
pg) containing 5000 cpm (^H)-DOC and Ifo ethylene 
glycol were evaporated to dryness in 2 ml. glass 
tubes in a vacuum oven at 35^0. Antiserum 
solution of appropriate dilution (DOC 1, 1:10,000;
1 1 2
0.5 ml. containing 2^ methanol and 0.5^ bovine 
gamma globulin in borate buffer, pH 7.5)»was added 
to each tube and mixed with a vortex mixer for 
,10 seconds. They were then left at room 
temperature for 1 hour and at 4^0 for a further 
hour before absorbing the free steroid component 
with dextran-coated charcoal (0.5 ml, 0.250 w/v 
dextran and 0.250 w/v Norit A charcoal in borate 
buffer, pH 7.5). If convenient, the 4^0 
incubation was extended overnight (see later).
After centrifugation at 4^0 ( 5 - 1 0  minutes,
2500 cpm) a 0.5 ml aliquot was taken for measurement 
of ( H) content.
Results.
Effect of pH on sensitivity of standard curve. In order 
to determine optimal pK at which to incubate 
samples, standard curves (O, 50, 100 pg. HOC) were 
prepared at pH 6.5, 7.0, 7.5, 8.0 and pH 8.5 
using borate buffer (O.IM). Results are shown in 
Table 13.
Maximum binding and the most sensitive 
standard curve was obtained at pH 7.5.
Temperature and time of incubation. The effect of 
variation in temperature and in duration of incubation 
on the sensitivity of the standard curve was studied 
by preparing replicate standard samples containing 
0, 50 and 100 pg deoxycorticosterone and incubating 
them at room temperature for 5, 3, 2 and 1 hour
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Incubation
pH '
0 Binding (4i) - DOC
0 PS 50 PS 100 pg
6.5 52 37 28
7.0 60 38 29
7.5 75 42 30
8.0 70 41 29
8.5 o 63 39 29
TABLE 13
Effect of variation of pli of incubation buffer 
on sensitivity of standard curve DOC 1 (l:10,000).
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respectively, followed by 1 hour incubation at 4^0. 
Another set of standard samples were incubated 
at 4^overnight. Similar standard curves were 
obtained with all incubation schedules.
3Quantity of H deoxycorticosterone. To show the 
effect of variation of the amount of P h)-DOC 
used on the sensitivity of the method, standard 
curves were set up using 1500, 2000, 2,500 
and 5)000 cpm (^I-l)-I)0C. Results shown in Table 14 
suggest that the assay is most sensitive when 
5000 cpm (^H)-DOC was used.
Separation of bound and free. In order to assess 
the efficiency of the separation of bound and free 
steroid and to determine the optimum ratio of 
dextran/charcoal, the standard curves were 
prepared and samples were incubated for 2 hours at 
room temperature and 1 hour at 4^0. Bound and 
free steroid were separated using half saturated 
ammonium sulphate or dextran coated charcoal 
(ratio dextran/charcoal 1:1, 1:2, 1:4, 1:6), 
Similar standard curves were obtained using both 
methods
Carrier protein* In order to determine the 
optimum amount of protein in the incubation 
mixture for maximum sensitivity, standard curves 
were set up using bovine globulin (0.2 - 10)
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VARIATION OF QUANTITY OF (^H)-DOC
Quantity 0 binding of -DOC
(^H)- DOC in presence of DOC.
0 pg 50 pg 100 pg
1500 cpm 60 4^ 30
2000 cpm 60 45 25
2500 cpm 60 45 25
5000 cpm 65 • 40 20
TABLE 14.
The effect of Variation of the quantity of ( n) 
DOC on the sensitivity of the standard curve 
obtained with antiserum DOC 1 at a dilution of
1:10,000 in borate buffer.
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bovine serum albumin (0.2 - 10) and gelatin (0.2 - 
10) as carrier protein (see Table 15). Maximum 
sensitivity was attained using 0.40 globulin. 
Sensitivity of the assay using gelatin was 
consistently lower than corresponding standard 
curves obtained using globulin as carrier protein.
Solubility studies. On several occasions standard 
curves prepared without ethylene glycol did not 
produce smooth curves. In samples without DOC 
binding of (^H)-DOC was anomalously low. ^This 
was presumably due to adsorption of the ( H)- 
DOC to the walls of the tube despite adequate 
silanisation of tubes or even due to breakdown of 
the ( H)“D0C when heated at high specific activity 
in absence of solvent. The problem was solved 
by addition of ethylene glycol to all samples.
This prevented adsorption of DOC to the walls of 
the tube.
Standard curves,. A typical standard curve is 
shown in Fig. 7.
Quality control data. The reliability of the 
method was investigated by areplicate analysis 
of. two pools of normal plasma and by analysis of 
blank samples (water, and plasma obtained from an 
adrenalectomised subject maintained on cortisol and 
9(K"fl^oroco^tisol). The results shown in Table 16 
were satisfactory in that blank activity was not
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Concentration # Binding of (^H) - DOC
of carrier
0 pg 50 pg 100 pg.
protein '
\  globulin
0,20 53 36 27
0,40 76 42 32
0,60 65 39 30
0.80 63 39 31
1.00 60 43 37
Gelatin
0.20 51 34 26
0.40 71 41 30
0,60 60 39 27
0.80 45 31 25
1,00 40 28 25
Bovine serum
albumen
. 0.20 54 32 24
0.40 62 34 25
0„.6^ 75 37 ' 27
0.8# 65 46 32
1.0# 65 48 36
Table 15 Effect of variation of protein and protein
concentration in incubation buffer on the sensitivity 
of standard curve DOC 1 (1:10,000),
1 1 8
POOL MEAN (ng/iOO) 
1 SD
COEFFICIENT
OP
VARIATION.
J 10.07 - 0.46 3.8
K 8.1 - 1.05 5.8
Water 0
Plasma
(Adrenalectomised
. 0
subject)
L.................... . .....
TABLE 16
Results of replicate analysis of 3 plasma 
pools and water.
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$ Bound (^H)-DOC
40
20
10
50 100 250200 300
pg DOC
Figure 7 « Antiserum DOC 1, standard curve (dilution 
1:10,000) using 5000 cpm (^H)- DOC and dextran coated 
charcoal (ratio 1:1)
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detectable and replicates shoved coefficients of 
variation of 3*8^ and 5.8% respectively
Specificity . This vas assessed firstly by the 
comparison of the cross reaction of the antiserura 
to DOC with that to a selection of compounds likely 
to be present in normal human plasma and, secondly, 
by comparing the results of assay with those from 
gas-liquid chromatography estimation (see below).
Cross reaction studies* Cross reaction of other 
steroids to antiserum DOC 1 are shown in Table 17*
The percentage cross reaction was calculated for 
each steroid (Abraham, 1969) from the formula ^  x
y
100, where X  is the amount of DOC required to displace 
50% of the (^H)-DOC bound to the antibody and y is 
the amount of a foreign steroid' (pg) required 
to displace 50% of the ÏÏ-D0C from the antibody.
The specificity of the method was further 
examined by comparison of concentration of 
deoxycorticosterone measured in the same sample by 
g.l.c, and by radioimmunoassay. For these data a 
linear regression equation, y = 0,83 x +0 .0 5  
was obtained and a correlation coefficient (r) of 
0,89 (Pig 8).
121
■
STEROID $ CROSS REACTION
ALDOSTERONE 0.3^
CORTISOL 0. 6f.
CORTICOSTERONE 0.8^
18 HYDROXY DEOXY­
CORTICOSTERONE 0.6^
DEOXYCORTISOL 0.4^
DEOXYCORTICOSTERONE ' 100#
TESTOSTERONE 0.1#
PROGESTERONE 1.0#
TABLE 17
Cross reaction of major steroids with antiserura 
DOC lo
1 22
COMPARISON of RADIOIMMUNOASSAY ond GAS-LIQUID CHROMATOGRAPHY 
for the ESTIMATION of PLASMA DOC
40
EO
o
z
X
X
o
O
10
' 20 30 40
CAS- L IQ UID . CHROMATOGRAPHY- og/lO O m I
50
Figure 8 Correlation of'concentrations of.DOC in
plasma sample measured by radioimmunoassay and GLC.
For these data a regression equation y = 0.83 ^ -p0.05 
with a correlation coefficient (r) of 0,89 was obtained
4.3. DISCUSSION
In the following discussion, the two techniques 
developed are examined individually. This is 
followed hy a short comparison of their 
advantagesand disadvantages,
4.3.1. Gas liquid chromatography with electron
capture detection. As previously mentioned 
in section 3 , gas-liquid chromatography with
electron capture detection possesses a high 
degree of sensitivity providing suitable stable 
derivatives can be prepared. In the past, this 
advantage has been somewhat offset by the 
susceptibility of the detector to massive, irreversible 
contamination or poisoning with prolonged loss 
of sensitivity. Removal of the contamination requires 
extensive chromatographic purification of 
biological extracts prior to GLC, Unfortunately, 
chromatographic ;nedia such as silica gel or paper 
themselves contain trace contaminants, Even after 
acid washing and multiple solvent extraction, silica 
gel extracts, when esterified with HFBA, stifl 
produce g.l.c, peaks indistinguishable from that 
of testosterone HPB. A large proportion of the 
contamination is of short retention time and 
produces a massive detector response which may 
persist over a long period. The detector returns
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very slowly to basal response and sensitivity of 
the detector may be greatly reduced for several 
days. Due to this contamination and subsequent 
loss of sensitivity, the response of the detector 
to steroid derivatives may be obscured or obliterated.
Use of detector by-pass valve as a means of avoiding 
detector contamination. (Cranmer, 1968)0 As 
stated above, the major fraction of the impurities 
responsible for detector contamination is^of short 
retention time on gas-liquid chromatography.
Diversion of this fraction from the detector by 
means of a by-pass valve avoids the early 
contamination, maintains high sensitivity and 
produces a trace which is suitable for quantitative 
analysis in the sub-nanogramme range (see Fig, 3).
This also allows large fractions of the final 
purified extracts to be applied to the column 
without loss of sensitivity, thus improving the 
sensitivity and accuracy of the assay, A further 
advantage is that larger numbers of samples can be 
processed per day without contaminating the 
detectora
Valve characteristics. Construction of detector 
by-pass valves in the laboratory poses a number of 
problems*
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The material from which the valve is 
constructed must be inert. Metals such as brass 
will catalyse decomposition of steroid 
derivatives at high temperature. Teflon (P.T.F.E.) 
proved a suitable material and was found to be 
chemically inert at temperatures less than 250*^ C. 
Unfortunately, certain grades of Teflon lose 
their inherent rigidity at high temperatures which 
may cause leaks in the system.
The internal volume of the valve must be low in 
order to prevent broadening of peaks with loss of 
chromatographic separation.
Valves constructed in the laboratory 
remained leak-proof for several weeks after which 
distortion of the barrel caused leakage and increase 
in volume, A more efficient commercial valve has 
since been installed in the gas-chromatograph oven. 
This rotary valve (Carle, Inc.) is constructed of 
pure teflon in a rigid metal case and has a very 
small internal 'volume. It causes no broadening of 
peaks or contamination of the detector and has 
remained completely efficient during several months 
of continuous use.
Steroid derivatives for gas chromatography with 
electron capture detection. DOC has been 
estimated in adrenal venous plasma and adrenal 
tissue incubates by g.l.c. with electron capture
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detection of the acetate derivative (Rapp and Eik 
Nes, 1905s Seth, 19.68), However, the affinity of 
the acetate derivative is low in comparison to 
polyhalogenated derivatives. Among the most 
effective of these is the bislieptafluorolbutyrate 
derivative formed by énolisation of the unsaturated 
carbonyl group in ring A (Clari: and Wotiz, 1963? 
Exley, 1967; Exley and Chamberlain, 196?; Horning 
et al, 19 68; Horning and Maume, I96 9).
Heptafluorobutyrates are used in methods for 
measuring the plasma concentrations of testosterone, 
androstenedione (van der Molen and Groen, I96 7;
Exley 1967? Kirschner and Coffman, I96 8), oestrogens 
(Wotiz et al, 196?? Munson et al, 1970) and 
catecholamines (Vessman et al, 1969).
The volatility of the bisheptafluorobutyrates■ 
allows gas chromatography to be carried out at 
relatively low temperatures (ISO^ - 220^C), thus 
reducing the risk of thermal decomposition.
Unfortunately, this advantage is somewhat offset 
by the instability of these derivatives on 
conventional chromatographic media such as silica 
gel (Exley and Chamberlain,196?), although they 
are slightly more stable on paper chromatography.
For this reason, recoveries must be measured before 
estérification with HFBA, The present results
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confirm the findings of Exley and Chamberlain (196?) 
that the estérification reaction is virtually 
quantitative. Dehennin and Scholler (1969), 
however, found 5-15/î by products on estérification 
of a number of steroids with IIP BA in acetone solution. 
It is therefore important to check the yield 
of the estérification reaction at frequent intervals.
Progesterone hPB was found suitable as an 
internal standard because of its similar molar 
response to electron capture detection an^ comparable 
retention time. Particular care was therefore 
taken to ensure removal of all endogenous progesterone 
in samples prior to gas chromatography.
Dehennin and Scholler (I9 6 9) studied in detail 
the mechanism of formation and the physico-chemical 
properties of steroid heptafluorobutyrate 
derivatives including DOC bis HPB. Results from 
gas chromatography - mass spectrometry and Kovats 
retention index reported are compatible with the 
findings of Dehennin and Scholler.
Other derivatives such as hexadecafluoro- 
octanoates reported by Kirschner and Taylor (1969), 
Exley and Dutton (1969)? also have very, 
high responses to electron capture detection 
and greater stability on thin layer 
chromatography and have also proved to be useful 
for measuring plasma concentrations of steroids.
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However, at the time this work was begun the 
necessary reagents v/ere not available in pure form.
Specificity and accuracy. Gas chromatographic mass 
, spectrometrie analysis of the purified and then 
esterified material from plasma indicated that the 
HOC HFB peak was pure. The absence of detectable 
DOC in the plasma from an adrenalectomised patient 
is additional evidence for the high degree of 
specificity achieved. Recovery of exogenous DOC 
and studies of replicate variation using 
purification methods (l) and (2) suggest that the 
technique is adequately accurate. This is further 
verified by the high correlation between plasma 
DOC concentrations obtained for the same samples 
using purification methods (l) and (2) and between 
method 1 and the radioimmunoassay of James et al 
(1971).
Sensitivity. ^High sensitivity is required for
analysis of corticosteroids in peripheral plasma.
The sensitivity of the present method (0,5 ng/lOO ml) 
is similar to those of the more sensitive g.l.c, 
techniques and double isotope techniques for 
estimating aldosterone, testosterone and oestrogens 
whose plasma concentrations are of the same 
order as that of DOC, However, while it is 
' theoretically correct to calculate sensitivity from
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replicate variation of estimates of plasma 
concentration near the limit of sensitivity of the 
method (Braunsherg and James, 1961) the replicate 
variation of the pool,used for the purpose was 
consistently lower than that of the normal plasma 
pools.and may have resulted in a fortuitiously high 
estimate of sensitivity.
Convenience, Using the shorter purification 
procedure (method 2) the analyses of a hatch of 
plasma samples hy the gas“Chromatography method 
requires a period of 2-3 days compared with 7-10 
days for a similar hatch hy double isotope derivative 
assays. Also, the small number of purification steps 
required (Hyde and Daigneault, 1968; James et al, 1971) 
results in a higher mean isotope yield which may 
increase sensitivity. The use of ( H)- labelled 
steroids as monitors of recovery in place of 
relatively low^  specific activity (^^c)-steroids 
further allows accurate counting in shorter time 
without the disadvantage of increasing the gross 
blank.
Npr'iai range. The concentration of DOC in plasma in 
normal subjects as measured by gas chromatography 
with electron capture detection comparesv/e 11 with 
the results reported hy other workers (see Table 
18) .
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AUTHORS NORMiL RANGE 
(PLASMA)
METHOD
BROWN AND Less than 5 ng - 10 Protein
STROTT (1971) ng/100 ml (n=2 3) Binding
ODLIE et al Mean 6.2 1 4,0 ng/ Double isotope
(1972) 100ml (n = 2 2) derivative assay
JiVMES et al 4 - 18 ng/100 ml Double isotope
(1971) (n = 24) derivative assay
JAMES et al 1 - 12 ng/1 0 0 ml Rad X 0 i mmun 0 assay
(1971) (n = 2 0)
WILSON and 4 - 14 ng/1 0 0 ml Gas
FRASER (1971) (n = 3 0) chromatography
(present method)
,U..... .
TABLE 18o
Methods for measurement of plasma DOG concentration 
showing normal range and method used.
131
4.3*2, Radi o i nnniino assay
During the period covered hy the work in this 
thesis (1969 - 1972) techniques of radioimmunoassay 
were rapidly established for assays of plasma- 
borne steroids and presented obvious possibilities 
of adaption to plasma DOC assay. It was therefore 
decided to compare its performance with the gas 
chromatography method. In order to do this, 
autisera were raised and tested and a simple 
purification and radioimmunoassay procedure was 
developed and evaluated.
Preparation of steroid protein conjugates. Using 
the original method of Erlanger et al (1937) for 
the preparation of carboxymethyloxime derivatives 
of DOC and aldosterone the main product in both 
cases appeared to be the 3? 20-dioxime which on 
conjugation with bovine serum albumin gave an 
insoluble precipitate. In order to prepare 
selectively the 3 carboxymethyloxime, the 
20-carbonyl gro"up was selectively reduced to 
the 2 0 -hydroxy group using the 20 - hydroxy-
steroid dehydrogenase. The 3-oxime of this reduced 
steroid was then prepared according to the method 
of Erlanger et al (l93?) after which the 20a{-hydroxy 
group was reoxidised to give the required 
3“Carboxymethyloxime of DOC and aldosterone.
Although the overall yield was
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very low, this procedure was suitable for 
preparation of small quantities of standard 3- 
carboxymethyloxime derivatives suitable for thin 
layer chromatography standards (Section 4,2.2.),
This allowed the continuous monitoring of a 
simpler direct procedure for preparation of larger 
quantities of these derivatives. The method of 
Erlanger et al (1957) involves the use of 
moderately strong alkaline conditions which are 
probably too severe for the selective preparation 
of the 3- oxime. It was found that a much higher 
yield of this compound was obtained by using mildly 
alkaline solution, lower temperature and a shorter 
reaction time.
Formation of antibodies. Steroids may be rendered 
antigenic by attachment to carrier proteins 
(Erlanger et al, 1957? Erlanger et al, 1959? 
Goodfriend and Sehon, 1958), Based on the early 
work of Liebernian et al (1959)? methods have been 
developed for linking hydroxyl functions on 
steroids to lysine groups on proteins using Schotten- 
Baumann or mixed anhydride reactions. However, as 
hydroxyl groups of mineralocorticoids are on rings 
C and D and are usually necessary for the production 
of the most specific antibodies, other methods such 
as oxime formation have been employed to link 
the protein to the 3- position of the steroid nucleus
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Antibodies produced by immunising animals 
with steroid protein conjugates exhibit greatest 
specificity to those parts of the molecule which 
are remote from the point of attachment of the 
protein to the steroid (Bieser et al, 1959?
Midgley and Niswender, 1970), Lieberman and 
colleagues (l959) developed antibodies to 
deoxycorticosterone - 21 - BSA and investigated 
the specificity of the antibodies using an hapten 
inhibition test. He showed that the dominant 
features in the steroid which determine antibody 
specificity were the nature of the oxygen function 
at position 11, the nature of the side chain 
function at position 17? and the o(, P-unsaturated 
carbonyl group in Ring A, In the present study 
antibodies have been developed to DOC and aldosterone 
using the 3-carboxymethyloxime- BSA conjugate. Both 
show good specificity with maximum cross reaction 
by other major ^ .steroids of Antisera to DOC
developed using the 21 - hemisuccinate - BSA 
conjugate are less specific cross reacting to 
a greater extent with deoxycortisol, Mayes and 
Nugent (1970)'and James et al (l97l) have both used 
the carboxymethy1oxime derivative linked to BSA 
to develop antibodies to aldosterone and 
deoxycorticosterone respectively. The latter 
antisera cross reacted completely with progesterone
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and to a lesser extent with corticosterone.
Attempts to produce antibodies in the rabbit to 
aldosterone - 3- carboxymethy1oxime - poly-l-lysine 
were not successful. This may be attributable to 
the possibility that induction of antibody response 
must include not only recognition of the hapten 
but also of the carrier protein. Levine et al (1963) 
in their study of poly-L-lysine conjugates 
in guinea pigs suggested that the ability to 
produce antibodies to poly-L-lysine conjugates 
depends on the capacity to metabolise the conjugate 
in the precise v;ay necessary to induce an 
immunogenic response.
In the studies with guinea pigs, no circulating 
antibodies were detected after immunisation with 
steroid protein conjugates (Table 14). This 
failure to raise antibodies to steroids may be due 
failure to recognise either antigen or carrier 
protein and consequently the process of antibody 
synthesis would not be induced. It is also 
possible that induction of antibody response and 
development of a high titre of antibodies in these 
guinea pigs require a considerably longer 
immunisation schedule than was possible in this 
experiment. However, anti sera obtained after long 
immunisation programmes may differ markedly in 
sensitivity, specificity and titre from those 
obtained by short immunisation programmes (Hum
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and London (1970),
Rodi0innunoassay of DOC in plasma.
Specif lei t>y o Specificity studies wâth anti serum 
DOC 1 indicate that cross reaction with other 
major steroids is less than IJw, However, steroids 
such as cortisol are present in plasma in very 
much larger concentrations than is DOC and hence 1% 
cross reaction with such steroids would obviously 
constitute a significant interference in the 
radioimmunoassay of plasma DOC, An adequate 
separation of DOC from these steroids is achieved 
on paper chromatography in Bush B3 system, Rp 
values for various corticosteroids in this system 
are shown in Table 4, Further confirmation of the 
specificity of the method was obtained by 
comparison of results with those obtained by gas- 
chromatography (see below).
Sensitivity and accuracy. The sensitivity of the 
method is adequate for the measurement of the plasma 
concentration of DOC in 2 ml, of plasma. Like gas- 
chromatography, this method would be suitable for 
duplicate assay of samples without requirement of 
large volumes of plasma thus increasing the 
accuracy of this method.
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B1ank sampies. There was no evidence of
any non-specific interference in the assay as 
blank values using water in place of plasma 
remained effectively zero. However, in order to 
avoid the problem of dealing with measurable blank 
values, scrupulous cleaning of glassware and 
solvents and thorough washing of chromatography 
paper were necessary.
Convenience. The analysis of a group of plasma
samples requires a period of 2-3 days which is 
similar to the gas chromatographic method,
4.3.3* Comparison of gas liquid chromatography 
and radioimmunoassay for measurement 
of plasma DOC concentration.
Comparison of results of analysis of plasma. The 
results of analysis of 29 samples by both methods 
(Fig. 8) showed a close comparison with no obvious 
systematic difference.
Specificity. In the gas chromatographic method, it 
is possible by physico-chemical means to prove that 
the compound extracted from plasma and measured 
by electron capture detection is Identical to 
standard DOC - bis HPB. Gas-chromatography - mass 
spectrometrie analysis is a convenient and efficient
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method of identifying the plasma product which is 
being measured. However, with radioimmunoassay, 
evidence of specificity is less conclusive.
Obviously one cannot measure the cross reactivity 
of every single steroid in plasma. Indirect 
evidence of specificity can be obtained by comparison 
of results with those obtained by other methods and 
by analysis of water and plasma from adrenalectomised 
subjects. These data confirm the specificity 
of this method in this department, Purtjaer, in 
patients receiving steroid drugs, the metabolites 
of which may not all be known, problems of 
specificity obviously occur. In such situations the 
gas chromatographic method offers the more 
reliable analysis.
Convenience, Both methods required a period of up 
to 3 days for analysis of plasma samples. However, 
the gas-chromatographic method requires much care 
and attention to maintain maximum, sensitivity.
For example, the columns require extensive ‘conditioning* 
at temperatures higher than normal operating 
temperature for 36 hours prior to use. Also, in 
order to avoid column adsorption of the small 
amounts of steroid present in samples, frequent 
injection of standard steroids and occasionally 
of silylating solution is required. In practice,
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it h.; s neon found that columns require replacing 
every few months. Gas supply to the electron 
capture detector and columns also requires 
purification hy use of molecular sieves which need 
periodic reactivation or replacement.
In these respects, much time is spent in 
maintaining the apparatus required for smooth 
functioning of the gas chromatographic method.
In contrast, the radioimmunoassay method 
requires little 'maintenance‘ work except ^ absolute 
cleanliness of solverits, apparatus and chromatography 
paper and preparation of solutions.
The major problem with radioimmunoassay 
techniques is development of specific and sensitive 
antisera. From the results of this study it would 
appear that there is no guarantee that antibodies will 
definitely be produced in sufficient titre to be 
useful in radioimmunoassay. More studies are'required 
to determine more reliable methods of raising 
antisera.
Range. The radioimmunoassay method has a
limited range of accurate measurement between 6 and 
300 pg. per sample which with a 2ml sample is 
equivalent to 75 ng/100 ml although this can be 
extended by doubling dilutions. The gas 
chromatographic method has no upper limit of detection 
as dilution of final solution allows quantitation of 
a wide range of concentration of DOC.
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PART II
STUDIES OF THE PHYSIOLOGY AND PUIBMACOLOGY
OF DOC,
l4o
INTRODUCTION
In the absence of suitable methods of 
measuring plasma DOC concentration little is kno^m 
about the mechanisms which control its plasma 
level although much can be inferred from studies 
of urinary secretion rate (see later).
The remainder of this thesis is concerned 
with the study of these control mechanisms^
The results of some of these methods also serve 
as further validation of the gas chromatographic 
method ( 2 ), used exclusively in these studies.
A brief outline of the biosynthesis and 
metabolism of DOC precedes the experimental section.
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REVIEW OF LITERATURE ON BIOSYNTHESIS
AND METABOLISM OF DOC
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2. REVIEW OF LITERATURE ON BIOSYNTHESIS AND
METABOLISM OF DOC.
A large number of steroids have been isolated 
and identified from extracts of adrenal glands 
(Hechter et al, 1951, 1953? Fincus and Romanoff, 
1955; Wettstein et al, 1955)» Although these may
all be synthesised by the adrenal gland only
those steroids which a.re found in adrenal effluent 
blood in significantly higher concentration than in 
the peripheral circulation can properly be'' termed 
secretory products.
Very little storage of steroid hormones occurs 
in the adrenal gland. Most of the liquid present 
consists of cholesterol or its esters which 
together with plasma cViolesterol are thought to 
provide the substrate for adrenal steroid
biosynthesis (Conn et al, 1950)» From studies of
^^■^G-acetate and  ^^ C-cholesterol metabolism, pr- sent 
evidence indicates that the adrenal steroids are 
synthesised from a small discreet pool 
respresenting only a fraction of adrenal cholesterol 
(Hechter et al, 1953; Caspi et ai, 1956, 1957? 1962)
Cholesterol to DOC. Cleavage of the cholesterol 
side chain by mitochondrial enzymes (Constantopoulas 
and Tchen, 1961) to form 3p-hydroxy- - 
pregnenolone occurs in at least two stages via 
20 oC"hydroxy-cholesterol (Solomon et al, 1956)
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and 20(X , 22-dihydroxycholesterol (Shimizu 
et al, 1961 a, 1961 b; Constantopoulas et al,
19 6 2; Levitan and Lieberman, 1956).
5This is followed hy conversion of the/i -
4pregnen0lone structure to the A  - 3 carbonyl 
structure typical of progesterone and the 
corticosteroids. This conversion is effected 
by the enzyme 3j3-hydroxysteroid dehydrogenase, 
whose presence has been demonstrated in the 
endoplasmic reticulum of the outer cells of 
zona fasciculata (Dawson et al, 1961) and by an 
isomerase which occurs in the microsomes of 
the same region (Ewald et al, 1964; Kruskemper 
et al, 1964). Further hydroxylation at position 
21 by microsomal enzymes yields deoxycorticosterone. 
Alternatively, l?(/{ -hydroxylation gives I7 0\ - 
hydroxyprogesterone which is a precursor of 
cortisol.
Steroid Hydroxylation. The normal order of 
hydroxylation of the steroid nucleus is 17cX ?
21 then lip respectively. For instance, 17c/- 
hydroxylase enzyme system will not act on 21- 
hydroxyl a ted substrate (Dorfman, 19 62) due to 
enzyme stereospecificity. These hydroxylation 
systems are mixed function oxidases which 
require NADPH as cofactor. The sequence of electron 
transfer is thought to involve flavoprotein, non-haem 
iron protein, cytochrome P43Û and also requires oxygen
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(Nakamura et al, 1966). The hydroxylases are 
probably genetically determined and familial 
enzyme deficiencies have been described (Cox, 
i960 ; Rosenbloom and Smith, I9 6 6). For example, 
virilising congenital adrenal hyperplasia 
(Bongiovanni and Root, 1963) is found in genetically 
and clinically different forms: 3p - dehydrogenase 
defect (Bongiovanni, 1961)and 21-hydroxylase 
defect (Jailer, 1951? Bongiovanni and Clayton, 1954)• 
The llp-hydroxylation defect causes marked reduction 
of cortisol and aldosterone secretion and consequent 
elevation of secretion of DOC and 11-deoxycortisol.
Zonation of adrenal cortex. Based on the work of 
Symington (1961) much is known about the morphology 
of the adrenal cortex. The human adrenal cortex 
consists of 3 main zones. Zona gloinerulosa, which 
is in the outer zone, is not clearly divided from the 
zona fasciculata, but merges with it. khere 
zona glomerulosa is absent, zona fasciculata extends 
to the capsule. The cells of the zona fasciculata 
are filled with lipid globules giving them a clear 
appearance and are clearly divided from the 
compact cells of the inner zone of the zona 
reticularis.
In contrast to the human adrenal cortex the rat 
adrenal cortex zones are more distinct zones. The
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outer zone, the zona glomerulosa lies under the 
capsule, is rich in lipid and separated from zona 
fasciculata by a thin layer of lipid-free cells.
The zona fasciculata, which constitutes about half 
of the cortex, is rich in lipid and may or may not 
pass abruptly into zona reticularis.
This morphological zonation of the adrenal 
cortex is accompanied by a functional zonation of 
the enzymes involved in corticosteroid biosynthesis 
(Grant and Griffiths, I96 2), However, deoxy­
corticosterone is of dual origin, occurring in 
zona glomerulosa and zona fasciculata. In the rat 
adrenal cortex the zona glomerulosa may be removed 
by stripping the capsule, from the remainder of 
the cortex. Capsular and decapsulated portions of 
rat adrenals produce equal amounts of DOC 
(Vinson and Whitehouse, 1969; Muller, 197o).
Further metabolism of DOC. DOG is further 
metabolised by two main routes, the biosynthesis of 
other active corticosteroids and its own biodégradation 
to a water soluble, excretable conjugate.
(a) Biosynthesis of other corticosteroids.
As previously stated, DOC occupies a unique 
position in the biosynthetic pathways of the 
corticosteroids as it is a precursor of all the knomi 
mineralocorticoids. The biosynthesis of aldosterone 
from DOC is not fully clarified but there is
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evidence that corticosterone (Giroud et al, 1956, 
195S; Mu1row and Cohn, 1959)? 18-hydroxy- 
corticosterone (Vescei and Kessler, 1970) and 
possibly 18-hydroxy-DOC (Nicolis and Ulick, 1965; 
Kahiit and Neher, 1965) are intermediaries of 
aldosterone biosynthesis.
(b) Degradation of DOC
Metabolism of DOC occurs mainly in the 
liver and kidney and involves reduction of^  ring 
A with resultant loss of biological activity and 
finally excretion, mainly in the urine (Biglieri, 
1965).
This product, tetrahydro-DOC glucuronide 
was first identified in the urine or normal 
subjects and later of subjects with Addison*s 
disease after oral administration of DOC. More 
recently it has been identified and its excretion 
rate found to be in the range 50-250 ug/day 
(Biglieri, 1965).
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3. DOC IN PLASMA.
The methods described in this thesis measure 
total plasma DOG concentration. However, some 
corticosteroids occur only partly in free solution 
in plasma the remainder being bound with variable 
tenacity to one or more fractions of plasma 
proteins (Sik-Nes et al, 1934). This protein- 
binding phenomenon has been studied mainly in 
relation to cortisol (see Mills, 1963).
Corticosteroids bind to at least two 
different protein fractions, namely albumin and 
corticosteroid-binding globulin (CBG or transcortin). 
While CBG has the highest affinity for corticosteroids, 
albumin has the higher binding capacity by 
virtue of its higher concentration in the blood (see 
section 3.3. on competitive protein binding methods).
The biological purpose of protein binding, 
whether for transport, slow release or inactivation 
of steroids, is not entirely clear but is obviously 
of considerable importance since most methods measure 
total steroid concentration which may not accurately 
reflect the activity of the steroid in vivo.
A similar problem exists with cortisol and studies 
of free cortisol, using equilibrium dialysis 
techniques, have been published (Burke 1969). As 
far as the author is aware no similar studies have 
been made of plasma DOC.
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The binding capacity of plasma proteins is 
known to be elevated during pregnancy (Gemzell 
1953; Martin and Mills, 1958) and oestrogen 
therapy (Taliaferro et al, 1956j Wallace et al,
1957). This is thought to be due to a general 
increase in concentration of the plasma proteins.
Both albumin and CGB are capable of binding DOC 
and from the metabolic clearance rate and biological 
half life (Schambelan and Biglieri, 1972) it would 
appear that DOC is to some extent protein-bound.
The nature and extent of this binding remain to 
be examined. The ability of plasma proteins 
to bind DOC has been exploited in an attempt to 
estimate plasma DOC concentration (see section 3.3.)*
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4. IlEVIKW OF LITERATURE ON FACTORS AFFECTING DOG
SECRETION AND PLASMA CONCENTRATION.
4.1. INTRODUCTION.
Steroid hormone secretion is controlled mainly 
by humoral influences as is evident from studies in 
which the adrenal gland has been transplanted 
elsewhere in the body of animals, severing all 
nerve connections, and has been able to function 
normally over a period of years. For example, 
Blair-West et al (I9 6 2) transplanted the adrenal 
gland of Merino sheep to the capacious skin folds 
of the neck. The secretion rate of aldosterone, 
corticosterone and cortisol responsed normally to 
environmental stimuli.
Factors which are known to*affect adrenocortical 
secretion are sho^vn in Fig 9. The major influence 
on cortisol, corticosterone and probably DOC would 
appear to be AC%U whereas aldosterone secretion 
is less sensitive to AGTH and responds more 
rapidly, in man at least, to renal influence.
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«STRESS*
V
(Emotional factors, 
surgery, pyrexia)
CENTR/vL NERVOUS SYSTEM
HYPOTHALAMUS
GRP
>  ANTERIOR PITUITARY
RENIN-
Negative
Feedback
ANGIOTENSINACTE
SYSTEM
CYCLIC AMP POTASSIUM
ZONAZONA SEROTONIN
PASCICULATA GLOMERULOSA
FIGURE 9
Factors known to affect adrenocortical 
secretion in normal human subjects.
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4,2. ANTERIOR PITUITARY AND ACTH,
AGTH is released from the pituitary as a result 
of a variety of stressful stimuli. Many events 
cause stress to man and animals; the 
effects of many of these have been tested and a 
few have been used for routine study of the 
sequence of events in the activation of the 
pituitary-adrenal axis. Emotional factors 
increase plasma cortisol concentration in man 
(Greenwood et al, 1966) and even mild stimuli 
such as movement of experimental animals may 
increase adrenocortical activity (Guillerain, 1967). 
Pain (Egdahl, I967), surgery (Hume and Nelson,
1955; Liddle at al, I9 6 2) and exposure to cold 
(D«Angelo, I96O; Boulouard, I960) have similar 
effects. Pharmacological stress such as insulin 
induced hypoglycaemia and pyrexia (Bliss et 
al, 1954) have been extremely useful tools 
for testing the efficiency of the pituitary 
adrenal axis while vasopressin, which may 
be related to corticotrophin releasing 
factor, is useful for assessment of anterior 
pituitary function.
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These stimuli cause parts of the central 
nervous system to activate the hypothalamus causing 
release of corticotrophic releasing hormone (CRF) 
which is carried to the anterior lobe of the 
pituitary by portal vessels, , CHF rapidly provokes 
release of ACTH (Purves and Sirrett, I9 6 7),
Mechanism of action of ACTH. Stone and Hechter (1954) 
postulated that ACTH stimulates the splitting of 
the cholesterol side chain by desmolase thereby 
increasing the rate of formation of pregnenolone,
Haynes and Berthet (1957) later proposed that 
ACTH stimulates the formation of cyclic 
adenosine - 5 , 5 -  monophosphate (cyclic AMP) which 
in turn activates phosphorylase by a kinase reaction. 
Adrenal glycogen is then converted into glucose - 
6 - phosphate which is metabolised by the 
hexose - monophosphate shunt pathway to yield 
NADPH2^, an essential cofactor in many of 
the hydroxylations involved in corticosteroid 
biosynthesis (see before). There is now a great 
deal of evidence to support this hypothesis.
For example, using rat adrenal slices in 
vitro, it has been demonstrated that 
addition of gluocose - 6 - phosphate 
and NAD? will enhance the production of
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corticosteroids (iCoritz and Peron, 1958), Dexter 
et al (1970) reported that ACTH also stimulates 
uptake of cholesterol from plasma, DOC 
secretion is promptly stimulated by administration 
of ACTH (Brown and Strott, 1971; Schambelan and 
Biglieri, 1972), Further studies of the effect 
of ACTH on DOG secretion are described in section 5.
Negative feedback control. The secretion of 
cortisol, corticosterone and DOC is mainly a 
consequence of ACTH stimulation (Cope and Black, 
1 9 58; Liddle et al, 1962). Conversely, 
administration of glucocorticoids in a dosage 
higher than physiologic,al requirement causes ; 
suppression of ACTH release and subsequent adrehal 
atrophy (Ingle et al, 1938), Similarly, elevated 
plasma cortisol concentration inhibits production 
of ACTH by the pituitary (Yates et al I96I). James 
et al (1966) showed that infusion of glucocorticoids 
(Dexamethasone, yl mg/hour) caused secretion of 
corticosteroids to cease within a few minutes of 
starting the infusion and concluded that, since 
such a rate of infusion of dexamethasone does 
not' interfere with adrenal responsiveness to AC^H, 
the rapid decrease in plasma cortisol level on 
infusion of dexamethasone reflected the effect of 
dexamethasone on the secretion of ACTH, During 
stress, the level of glucocorticoids in plasma
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required to inhibit ACTH roloase is set at a 
higher level. For example, even massive doses of 
glucocorticoids do not fully inhibit adrenal 
responsiveness to surgery, pyrexia and other 
stressful stimuli (Sstap et al, 1963).
Administration of dexamethasone has been shown 
to suppress DOC secretion (Bledsoe et al, 1966; 
Schambelan and Biglieri, 1972). Further 
studies are described in section 5*
Nycthemeral Rhythm . The secretion of cortisol 
and probably also DOC (James et al, 1971) does 
not occur at a constant rate during the day, but 
is high in the early hours of the morning,
decreasing to a minimum at about midnight. This
variation is reflected in the plasma concentrations 
of these steroids and is called a nycthemeral 
rhythm. The.recent availability of accurate 
techniques for r^jeasuring plasma concentration of 
ACTH (Greenwood, I96 8) confirm earlier reports 
(Ney et al, I9 6 3; Clayton et al, I963) that this 
corticosteroid rhythm is secondary to that of 
ACTH.
The rhythm is probably a manifestation of the 
cyclic functioning of the hypothalamus (Yates 
et al, 1961). Because of the variation of plasma
concentrations of these steroids during the day, it is
important that blood samples are taken at standard times
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Recently it has been shown that secretion 
of ACTH and consequently corticosteroids is phasic.
The frequency of these phases is greatest in the 
early morning giving rise to maximal plasma 
concentrations of corticosteroids (Heilman 
et al, 1970).
4.3. THE KIDNEY
There is considerable evidence to suggest that 
the main product of the zona glomerulosa, 
aldosterone, which responds to changes of electrolyte 
status, is largely under the control of the kidney 
(Fraser et al, I96 9). The zona glomerulosa, also 
synthesises DOC (see section 2) and the possibility 
of a renal involvement in the control of secretion
of this steroid cannot be excluded.
Rcnin-angiotensin system. (Fig. lO). Renin is
an enzyme produced by the kidney which acts
upon a plasma globulin (renin substrate) to produce 
a decapeptide, angiotensin 1 which is subsequently 
converted to an octapeptide, angiotensin II, 
on passage through the lung. Angiotensin II is a 
powerful vasoconstrictor, and stimulates 
aldosterone secretion by the adrenal cortex (Fraser
et al, 1969).
Angiotensin and DOC. Brown and Strott (l97l) could
detect no change in plasma DOC concentration on 
infusion of angiotensin II at a rate of 6-8 ng/Kg/min.
RENIN SUBSTRATE
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for 60 mins. This amount was sufficient to raise 
diastolic blood pressure by 20 mmlig. However,
Davis et al (1968) demonstrated a four-fold rise 
in DOC secretion in the dog during infusion of 
angiotensin at a rate of 50 ng/Kg/min for 3 hours.
They also reported that in chronic renal failure in 
the dog, when the plasma angiotensin should be 
raised, DOC secretion remained normal. In the various 
conditions associated with increased activity of 
the renin-angiotensin system, including malignant 
hypertension, juxtaglomerular-cell hyperplasia and 
some cases of essential hypertension, it is known 
that DOC secretion is within normal range (Biglieri 
et al, 1968).
The explanation for these conflicting results 
may be that physiological doses .of angiotensin II, 
i.e. the dose required to cause a minimal rise in 
diastolic blood pressure may promote only aldosterone 
secretion whereas very large doses may also 
increase DOC secretion. This may be due to stress 
since cortisol and corticosterone are also raised 
in these circumstances (Blair-West et al I96 8) 
or ..saturation of the capacity of the adrenal cortex 
to convert DOC to aldosterone.
Sodium Status. Changes in plasma sodium or total 
body sodium may alter the sensitivity of blood 
pressure to angiotensin II,
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Brown and Strott (l97l) and Oddie et al 
(1972) could detect no change in plasma DOG 
concentration during sodium depletion (10 m, equiv. 
sodium intake/day). However, under similar 
dietary sodium deprivation Bledsoe et al (1966) 
showed a rise in DOG secretion rate. In order to 
demonstrate this rise, the subjects were treated 
with dexamethasone and metapyrone throughout the 
study to inhibit lip and 17 ^  hydroxylation and also 
the production of cortisol as a result of ACTH 
stimulation. In this way the relatively small 
changes in DOC secretion caused by sodium 
depletion could be detected as they were not 
obscured by larger changes due to ACTH variation. 
Visser and Cost (1964) found low aldosterone 
secretion rate and high corticosterone and DOC 
secretion rates during sodium depletion of a 
subject with 18"hydroxylation deficiency. This 
would result in decreased aldosterone secretion rate 
and consequently increased secretion of DOC and 
corticosterone which are both precursors of 
aldosterone.
Studies of the effect of sodium depletion on 
plasma DOC concentration are described in section 5.5.
Other electrolytes. In vitro studies of 
corticosteroid biosynthesis have shown that several 
cations including sodium, potassium, rubidium,
l6l
ammonium,and caesuim may increase biosynthesis of 
aldosterone in adrenal slices (Muller, 1965a, b ; 
Blair-West et al, 1968). Muller (1968) demonstrated 
that production of DOC by quartered rat adrenals 
was stimulated by a high potassium concentration. 
Similar findings have been described in 
superfusion and pure cell preparation studies 
(Albano et al, 1972). The following section 
describes the investigation of factors affecting 
plasma DOC concentration.
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5. STUDY OF FACTORS AFFECTING PLASMA DOC 
CONCENTRATION IN NORMAL HUMAN SUBJECTS
163
5.1. Introduction
As will be apparent from the preceding 
review, few studies have been made of the factors 
which influence plasma DOC secretion in man, 
presumably due to inadequate methodology. The 
aim of the following work is to study a number of 
factors which have been reported, or might be 
predicted to affect plasma DOC concentration 
in normal man.
5.2. General methods
Plasma 11-hydroxycorticosteroids were 
measured by the Steroid Biochemistry Department 
of the Royal Infirmary, Glasgow using a 
fluorimetric method (Mattingly , 1962, normal 
range 6 - 22, mean 12 ug/lOO ml). Plasma renin 
concentration ivas measured by the method of 
Brown et al (1964; normal range 4-20, mean 8,4 units/ 
litre). Plasma angiotensin II was measured 
by radioimmunoassay (Dusterdieck and MeElwee,
1971; normal range 5-35, mean l6 pg/ml).
Serum and urinary electrolytes were measured 
by flame photometry. These estimations were 
carried out by other members of the staff 
of the MRC Blood Pressure Unit.
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5 .3 .1. THE EFFECT OF AGTH ON PLASMA DOC 
CONCENTRATION.
Methods.
In order to study the effect of ACTH on 
plasma DOC concentration, the following 
study was undertaken in 5 normal subjects on 
unrestricted diet. The subjects remained supine 
throughout the study.
An indwelling cannula was inserted by 
a medical colleague into the subjects' peripheral 
arm vein under local anaesthetic and one 
hour later basal blood samples (40 ml) were 
taken. p^“^4 i ug. Tetracosactrin;
Ciba, Ltd.) was injected via the indwelling 
cannula and blood samples (25 ml) were taken 
at intervals. All samples were treated as 
previously described.
Results.
Plasma concentrations of DOC and 11-hydroxy- 
corticosteroids are illustrated in Pig. 11,
In these experiments, maximum DOC 
concentration (15 mins) always occurred before 
that of 'cortisol' (30 mins). The concentration 
of both substances had returned to basal levels 
after 90 mins.
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Figure 11,
Plasîaa concentration of DOC (ng/lOO ml) and * cortisol»
(ug/iOO ml) after injection of ACTH (l ug)
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It is proposed to report these results 
with experiments 5.3.3. (Wilson, Love 
and Fraser, 1973).
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5.5.2. THE EFFECT OF INSULIN INDUCED HYPOGLYCAEMIA 
ON PLASMA DOG CONCENTRATION.
Introduction
Reduction of blood glucose level by 
administration of insulin is an effective stress 
stimulus which causes release of corticotrophic 
releasing factor (CRF) from the hypothalamus,
CRF stimulates release of ACTH from the 
pituitary (Bliss et al, 1954; Purves & Sirrett, 
1967). This is a convenient means of studying 
the effect of physiological rises in endogenous 
ACTH concentration on plasma DOC concentration.
Method
Two normal?supine jfasting subjects were 
given insulin (0.15 units/insul'in/Kg), Blood 
samples (50 ml) were taken for measurement of 
blood glucose levels and plasma concentration 
of DOC and cortfsol.
Results
A marked fall in blood glucose levels was 
observed in both subjects (Fig.12),
Plasma DOC concentration rose promptly to a 
maximum concentration after 30 minutes. Plasma 
cortisol also rose with maximum level occurring after 
45 minutes. Both DOC and cortisol had returned to 
basal levels after 20 minutes.
or.
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Plasma concentration of DOC (ng/lOO ml) 'cortisol' 
(ug/100 ml) and blood glucose (mg/lOO mi) after 
injection of insulin.
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5 .3.3 . DISCUSSION
The ability of ACTH to increase DOG secretion 
is well documented (see before) and this small 
series of experiments confirms such a relationship. 
The experiments involving administration of 
synthetic ACTH may have been pharmacological 
since in two of the subjects very high levels of 
ll^hydroxycorticosteroids were achieved.
However since plasma ACTH levels were not measured 
the extent of adrenocortical stimulation is 
difficult to assess.
However it is clear, firstly, that DOC 
secretion is promptly increased and, secondly, 
that the duration of the response is shorter 
than that of cortisol.
Endogenous release of AGTH, induced by- 
hypoglycaemia, results in an increase in 
circulating ACTH levels approximately to high 
physiological levels, although such gross 
hypoglycaemia would rarely be encountered in 
normal subjects. In the two patients subjected 
to this experiment plasma cortisol and DOC 
levels were again increased. Again it appeared 
that plasma DOC concentration rose more quickly 
than cortisol and may have been maximal before the 
first available sample (30 mins). Further studies
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are necessary to establish this point.
From these preliminary experiments 
therefore, it would appear that the response of 
plasma DOC concentration to a rise in plasma 
ACTH concentration is 
more rapid and 
of shorter duration than 
that of cortisol,
ACTH is known to exert its effect early in" the 
biosynthesis of corticosteroids. A possible 
explanation for these results is that the 
capacity of the adrenal cortex to hydroxylate 
at the lip position is temporarily exceeded and 
that there is a consequent increase in the 
tissue concentration and hence secretion of 
11 deoxy-compounds. This is supported by the 
fact that 11-deoxy-cortisol behaves in a 
similar fashion to DOC during Insulin induced 
hypoglycaemia (Mason, personal communication, 1971) 
whereas the response of corticosterone 
resembles that of cortisol. Also the 
corticosterone response to stress and to 
administered ACTH is indistinguishable from 
that of cortisol (Fraser 190?), but no 
reliable comparison of DOC and 11-deoxycortisol 
is yet available.
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ACÏH therapy is commonly used in 
the treatment of inflammatory conditions such 
as arthritis and the electrolyte and body fluid 
disturbances occurring during such therapy may 
in part be due to increase in the circulating 
levels of DOC
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5.4. THE EFFECT OF ANGIOTENSIN II ON PLASMA 
DOC CONCENTRATION.
Me thods
The effect of angiotensin II on plasma DOC 
concentration was studied in 3 normal male 
subjects on unrestricted diet. The subjects 
remained supine throughout the study. An 
indwelling cannula was inserted into a peripheral 
vein in each arm under local anaesthetic. ^ 
Dextrose (5/® aqueous) was infused for one hour. 
Two basal blood samples (50 ml.) were then taken 
with an interval of 15 minutes between samples. 
Angiotensin II (Hypertensin; Ciba Ltd.) was then 
infused continuously for 1 hour at 2 ng/Kg/ 
min. and then for a further hour at 8 ng/Kg/min. 
Blood samples (50 ml) were taken after 15,30,
60 and 120 minutes of angiotensin II infusion.
Results
Blood pressure did not increase in any subject 
on the lower rate of infusion of angiotensin II, 
but increased significantly during the higher 
rate of infusion. Plasma concentrations of 
angiotensin IX and DOC are shown in Figure 13# 
Despite the prompt and sustained rise in 
angiotensin II concentration to levels above the
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angiotensin II during angiotensin II infusion.
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normal range, plasma DOC concentrations did 
not rise.
Discussion
Infusion of angiotensin II increases 
plasma aldosterone concentration (Fraser 196?), 
and secretion rate (Laragh et al, i960) 
although its effects may vary from species to 
species (Mulrow and G-anong, I96I), Currently 
it is thought that this effect occurs early in 
the biosynthetic pathway of aldosterone possibly 
during the conversion of cholesterol to 
pregnenolone (Muller, 1970) and it may therefore 
seem surprising that plasma DOC concentration 
does not rise during angiotensin II infusion. 
However, if as seems likely, the conversion of 
cholesterol to aldosterone via DOC is enhanced 
no increase in plasma DOC concentration would be 
expected if the rate of conversion of DOC to 
corticosterone,increased in proportion to the 
rate of pregnenolone formation. There is 
evidence that conversion of corticosterone to 
aldosterone is more efficient in situations of
I
high aldosterone production (Blair West et al, 1968; 
Tait et al, 196I).
Few studies of the effect of angiotensin II 
in vivo have been carried out in man. Brown et al
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(1972) infused angiotensin (6-10 ng/Kg/min;
30 mins) into 5 normal subjects receiving 
metapyrone in whom ÂCTH secretion had been 
abolished by dexamethasone administration.
Plasma DOC concentration rose in the absence of 
any effect on the 17 hydroxy analogue of 
DOC, 11-deoxycortisol, which is secreted only 
by the zona fasciculate. This would suggest 
that angiotensin II exerts its effect only 
on the zona glomerulosa and that the increased 
quantity of DOC in the circulation originated 
solely from this source. Possibly in conditions 
where the function of the zona fasciculate is not 
suppressed, as for example in the experiments 
described here, DOC may diffuse from the zona 
glomerulosa to the inner zones and be consumed 
within the gland. In a previous study (Brown 
and Strott, 1971) dexamethasone was not used 
and plasma DOC concentration fell to levels 
undetectable by the competitive protein 
binding method used. This may also be due, 
to increased efficiency of conversion of DOC to 
corticosterone and aldosterone.
Some studies of the effects of angiotensin II 
in vitro have been carried out in the rat and 
beef (Saruta et al, 1972) adrenal tissue, 
but as far as the author is aware no
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measurements of DOC have been made. In any case, 
the effects of aldosterone production have 
remained in dispute and, particularly where 
incubation techniques have been used, conclusions 
are difficult to draw if the rapid destruction 
of angiotensin II in vivo and in vitro 
is borne in mind.
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5.5. THE EFFECT OF SODIUM DEPLETION ON PLASMA 
DOG CONCENTRATION
Method
The effect of sodium depletion on plasma DOC
concentration was studied in 4 normal subjects (3
male) who were placed, on a. low sodium diet (20
m.equiv./day) for 5 days. Blood samples (50 ml)
were taken and 24 hour urine collections were
taken during the period of unrestricted diet
prior to the sodium depletion, during the period
of sodium depletion and then during a further
3 days of unrestricted diet for the measurement
of plasma concentrations of DOC, angiotensin II,
aldosterone and electrolytes and urinary electrolyte
excretion.
Results
Electrolyte balance was achieved after 
two days of dietary sodium restriction (Table 21 a)
The mean cumulative sodium loss for the four 
subjects during the restriction was 98 m.equiv.
Plasma angiotensin II and aldosterone both 
rose in all subjects above the normal range (Table 20, Fig.i4 
while plasma sodium concentration fell (Table 21b)
No consistent change in plasma DOC concentration 
was observed (Fig 14, Table 19).
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No Angio
II
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1
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1
DOC '
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IM
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1
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1
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I
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1
1
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1
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1
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1
j 6.8
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1
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1
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1
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J
56 1 5.2
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i
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TABLE 19
Levels of angiotensin II (pg/ml) and DOC 
(ng/100 ml) in plasma during dietary sodium 
depletion.
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Subject Plasma aldosterone concentration ng/lOO ml
DAYS 1 4 6 8 9 12
IM 14 14 14 17 17 6
PM 6 6 26 66 55 7
JY 11 10 26 38 36 28
DRL 8 7 36 57 51 7
TABLE 20
Plasma aldosterone concentrations (ng/100 ml) during 
dietary sodium depletion. Samples were taken 
at times shown on Figure
Normal range of plasma aldosterone is 4 - 17 ng/100 ml.
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Subject Day 1 Day 2 Day 3 Day 4 Day 5
IM -36 —24 -7 +3 +4
PM -95 -23 -8 +8 +9
JY -74 -10 +2 4-8 +4
DRL
I
-90
,
-55 -10 0 4-2
TABLE 21. (a)
Sodium balance in 4 subjects during 5 days 
dietary sodium depletion.
Sodium loss denoted - 
Sodium retention denoted +
Results are expressed in m.equiv. sodium.
182
I- " - . .
Subject
1
Na K
2
Na K
3
Na K
■
4
Na K
5
Na K
6
Na K
IM 143 3.8 139 3.6 139 3.6 139 3.6 — ” 142 3.4
PM 141 3.3 141 3.3 139 3.3 139 3.1 - - 140 3.3
JY 142 3.8 140 3.8 139 3.6 139 3.6 - - 142 3.6
■ DRL 142 3.5 138 3.4 139 3.4 138 3.4 - — 140 3.5
TABLE 21.
Plasma electrolyte concentration (m.equiv,/l). during 
dietary sodium depletion. Samples were taken as 
shown in Figure 14.
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Discussion
Although the degree of sodium depletion, in 
the subjects studied was sufficiently severe 
to reduce plasma sodium levels by a mean 
of 3.5 m.equiv,/litre and fo raise aldosterone 
and angiotensin levels to 2-6 times normal, 
no significant changes occurred in plasma DOC 
concentration. This is compatible with the 
results of the previous experiment in which 
angiotensin II failed to increase plasma DOC 
concentration. It could perhaps have been 
predicted that stimulation of the renin- 
angiotensin system within physiological limits 
would not increase plasma DOC concentrations. 
Also as in the previous experiment, any increase 
in DOC biosynthesis may have been absorbed by 
increased efficiency of aldosterone biosynthesis 
which increased.
Relatively mild changes in sodium status 
also do not appear to alter DOC secretion which 
is in common with cortisol and corticosterone 
(Eraser, I9 6 7). Brown and Strott (1971) report 
similar findings in a small group of normal 
human subjects. Of the major corticosteroids 
therefore, only aldosterone responds to dietary 
sodium deprivation in normal man although small 
increases in plasma corticosterone have been
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reported in sodium depletion associated with 
sodium-losing renal disease (Fraser 196?)*
Plasma DOC concentration was not measured in 
this study but plasma cortisol was not affected 
suggesting that the effect on the pituitary 
adrenocortical axis was not significantly altered. 
Further studies of the effect of more severe 
sodium depletion on plasma DOC concentration 
would therefore be of interest. Such a study 
including also a period of total fasting iii 
obese subjects is described in section 9 —
Recent work both in vitro and in vivo 
indicates that potassium concentration may be an 
important factor in the control of steroid 
biosynthesis by the zona glomerulosa (Muller, 
1970). While it seems likely that, like 
angiotensin II, the effect of potassium may be 
early in the metabolic pathway of 
pregnenolone toAaldosterone (Muller 1970) a 
later effect cannot be excluded. The effect 
of potassium and the inter-relationship of 
sodium, potassium and mineralocorticoid 
secretion remains to be evaluated.
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5.6. ‘TUE EFFECT OF POSTURE ON ]'LASMA DOC 
CONCENTRATION
Method
The effect of posture on plasma DOC 
concentration was studied in two normal male 
subjects on unrestricted diet. An indwelling 
cannula was inserted in a peripheral arm 
vein under local anaesthetic. The subjects remained 
supine on a tilt table for 2 hours and then 
were tilted to an upright position for a further 
2 hours. Blood samples (50 ml), were taken 
at times shown in Pig. 15 for the measurement 
of plasma DOC and angiotensin II concentrations.
Results
As shown in Fig. 15, plasma angiotensin 
II concentration rose above normal range 
on tilting to upright position, but plasma 
DOC concentration showed no significant change.
Discussion
Under these experimental conditions, the 
rise in plasma angiotensin II is well documented 
and again shown in these experiments. As 
discussed in previous sections, an increase 
in plasma angiotensin II within physiological
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The effect of posture on plasma concentrations 
of DOC and angiotensin II,
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limits is unlikely to produce an increase in 
plasma DOC concentration*
In addition to the rise in plasma angiotensin 
II) the assumption of an upright position causes 
a redistribution of blood in the vascular system 
which is counteracted to some extent by increasing 
peripheral blood vessel constriction, A fall 
in splanchic blood flow should also result in 
a reduction of metabolic clearance rate and 
consequently a rise in plasma DOC concentrations 
such as have been shorn: for plasma aldosterone 
(Bougas et al, 1964), This did not occur,
A possible explanation may be that although DOC 
does not operate the negative feedback mechanism 
whereby AGTH secretion is halted, it 
is nevertheless ACTrl-dependent, Thus a rise in 
cortisol levels due to a general fall in 
corticosteroid metabolic clearance rate by 
suppressing ACTH secretion will also prevent 
plasma DOC concentration from rising. Aldosterone 
concentration which rises in these circumstances 
(Balikian et al, 1968) is largely 
independent of ACTH.
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5.7. G5ME1UL GOPPJENTS AND SUI-7IARY
In section 5 studies of some of the factors 
ImoTOi to affect aspects of adrenocortical secretion 
have been described. It was found that of the 
potential stimuli tested, only ACTH significantly 
affected plasma DOG concentration and that the 
rise in the level of DOC may be more rapid and 
of shorter duration than that of cortisol.
Therefore in any investigation of DOC in man the 
same precautions must be taken when sampling 
blood as are important in the study of cortisol. 
Samples must be taken at the same time of day, 
preferably early in the morning to avoid the 
effects of diurnal variation and under conditions 
of minimal stress.
On the other hand changes in posture and 
dietary sodium intake did not alter plasma DOC 
and unless other substances such as aldosterone 
or angiotensin are under investigation the 
standardisation of these factors may be less 
important. The degree of haemorrhage involved in 
the experiments described here did not affect 
plasma DOG concentration.
Several known products of the adrenal 
cortex (see section 1 ) possess mineralocorticoid 
activity and may contribute to sodium-homeostasis
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To be effective such hormones must, in addition 
to promoting sodium retention by the kidney, 
respond to small changes in some parameter 
of the body's sodium status. While DOG is a 
mineralocorticoid of some potency and must 
contribute to the total effect of the adrenal 
cortex on the renal tubules its secretion and 
therefore plasma concentration do not respond 
to changes in sodium status at least within the 
normal physiological range. It is therefore 
unlikely that DOC is important in the fine 
control of sodium status in normal man.
However it is well known that 
administration of large doses of DOC derivatives 
to animals particularly when salt intake is high, 
may lead to severe electrolyte disturbances and 
hypertension. It is therefore conceivable that 
abnormally high DOC secretion in man, as in 
congenital adrenal hyperplasia due to partial 
or total absence of adrenal llp-hydroxylase 
activity or following therapeutic administration 
of ACTH, may lead to similar electrolyte and 
blood pressure disturbances.
The following sections describe studies of 
plasma DOC concentration in hypertensive rats and 
man.
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6, SOME STUDIES OF THE EFFECTS OF DOC 
ADMINISTRATION IN MAN AND THE RAT
191
Administration of derivatives of DOC
Much of the pharmacology of DOC in man 
and animals is based on results of experiments 
using derivatives such as DOC acetate (DOCA) 
or DOC pivalate. Experiments in man and rats 
were conducted to test the efficiency of 
absorption and the rate of hydrolysis of 
DOC esters in vivo and also to determine the 
plasma concentration of DOC attained by 
injection of DOC esters in quantities 
sufficient to produce hypertension in rats.
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6.2, THE EFFECT OP DOCA ADMINISTRATION ON 
PLASMA DOC CONCENTRATION IN MAN.
Methods.
DOCA (5 mg/oil, i.m.) was given to two normal 
subjects. Blood samples (25 ml) were taken 
immediately before the injection and at intervals 
thereafter for the measurement of plasma 
concentrations of DOG and DOCA.
After extraction of the plasma the ngutral 
extract was applied to a paper chromatogram (Bush, 
B5j 5 hours). The area corresponding to DOC and 
DOCA were eluted with nanograde methanol and the 
DOC extract was treated as detailed in gas 
chromatographic method 2. The DOCA extract was 
hydrolysed using saturated methanolic sodium 
carbonate (see gas chromatographic method l) and 
then re-chromatographed in the same system (Bush B5, 
5 hours). DOG area was eluted and after 
estérification with HFBA was applied to gas 
chromatography with electron capture detection.
Results.
Plasma DOC concentration rose rapidly 
to a maximum concentration after 1 hour and 
returned to basal levels within 24
hours. No DOCA was detected in any of the samples.
193
DOC
ng/lÛOm!
■ 300n
200
o PAM 
o Rf
100
HOURS
Figure l6.
Plasma DOC concentrations (ng/100 ml) in two 
normal subjects after injection of DOCA (5 mg/ 
coconut oil, i.m.).
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It is hoped to publish this work as 
part of a study of DOG induced hypertension in 
rats conducted in our department in 
cooperation with several colleagues.
195
6.3. THE EFFECT OF DOC PIVALATE ADMINISTRATION
ON DOC CONCENTRATION IN THE BLOOD OF THE RAT
Method
Under general anaesthesia a small indwelling 
polythene cannula was inserted in the jugular 
vein in 6 Sprague-Dawley rats. Twenty four 
hours later a basal blood sample (0 ,2 5 ml) was 
taken in a heparinised syringe from each rat 
while conscious. DOC pivalate (l2,5 mg,^i.m. 
25-30mg/Kg) v:as injected in 3 rats and saline 
(0,5 ml, i.m.) in 3 control rats. Blood samples 
were then taken at intervals. Whole blood DOC 
concentration was measured by haeiaolysing the 
red cells with an equal volume of water prior to 
extraction. Purification and assay were as in 
gas chromatographic method 2.
Results.
'The concentration of DOC in whole blood in 
both sets of rats are shown in Fig. 17. Maximum 
DOG concentration was attained 12 hours after the 
injection, DOC concentration in the control rats 
showed no rise but varied slightly throughout the 
period of study.
This experiment was a preliminary study set 
up in order to investigate the feasibility of
Whole blood DOC 
concentration iig/nil
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Whole blood DOC concentration in ( <? ) DOCA and 
saline ( o ) injected rats*
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measuring DOG concentration in small blood 
samples in the rat.
As previously stated the results of this 
study will be published later (Schalekamp et 
al, 1973).
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6.4. DISCUSSION
The experiments with DOGA in man demonstrate 
that DOG is rapidly absorbed and hydrolysed in vivo 
giving rise to very high levels of DOC in plasma 
within 1 hour of administration of DOGA. Blood 
esterases must be capable of very rapid 
hydrolysis of the absorbed DOGA since DOGA was 
not detectable in any sample.
The injected DOGA is likely to have the same 
effects as DOG.
In experiments with rats, whole blood was 
used in preference to plasma because repeated sampling 
of blood from each rat was required, Smaller 
blood samples were more likely to avoid 
stimulating corticosteroid secretion. As 
separation of plasma from such' small samples is 
difficult whole blood was used in this study.
The concentration of DOC in whole blood in 
the control rat's remained normal throughout the 
study indicating that insertion of the plastic 
cannula and repeated blood sampling did not 
appear to influence plasma DOG concentration.
Very high levels of DOC in whole blood were 
obtained in the DOC-pivalate treated rats 
indicating again that absorption and hydrolysis of 
the administered DOC ester occurs.
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This experiment also demonstrated the 
suitability and validity of the gas chromatographic 
method for the study of hypertension and DOC in the 
rat. The high sensitivity of the method permits 
repeated measurement of DOC concentration in 
individual rats and consequently provides an 
efficient monitor of the levels of DOC, 
maintained over a prolonged period, which are 
sufficient to cause hypertension in the rat. In 
studies of DOCA-induced hypertension, the rats 
are normally unilaterally nephrectoinised and 
then given saline as drinking water. Injections 
of DOCA given 2-3 times week induce hypertension within 
6-8 weeks (Hall and Hall, 1968).
This present study indicates that under these 
circumstances the level of DOC in whole blood 
in the rat is on average several times higher 
than in control rats. However, in the rat DOC 
is the major mineralocorticoid and thus direct ' 
extrapolation of these results to the study of 
hypertension in man may not be valid. It is not 
entirely clear whether plasma DOC levels in man 
similarly elevated over a period of years would 
cause hypertension (see section 7)#
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PLASMA DOC CONCENTRATION IN HUMAN
HYPERTENSION
201
7.1. Introduction
In hypertensive disease in man, low plasma 
concentrations of renin and angiotensin are often 
hut not always related to high plasma levels 
of aldosterone (Brown et al, 1971). It is 
possible that under certain circumstances other 
corticosteroids such as 18-hydroxy-DOC (Melby et 
al, 1971; Genest and Nowaczynsky, 1970) or DOC 
may be involved in the aetiology of the^ disease.
The following section describes the investigation 
of the levels of plasma DOC in such cases of 
hypertensive disease with low plasma renin and 
angiotensin and low or normal aldosterone.
7.2. Methods
Plasma DOC levels were measured in 31 
hypertensive patients (21 female). The average 
blood pressure in the individual cases as outpatients 
before treatment ranged from 149/106 to 230/145 
mmHg (mean for the whole group was 191/120 mmHg) 
and their ages ranged from 20 to 65 years. There 
were no symptoms or signs in any of the patients 
to suggest Cushing's syndrome, phaeochromocytoma 
or aortic coarctation. No abnormal sex 
characteristics were noted. None of the patients 
had peripheral oedema, papilloedema, retinal
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haemorrhage or exudates. No evidence of renal 
disease was noted.
21 of these patients were selected for 
plasma DOC measurement because earlier 
investigations had shown evidence of mineralo­
corticoid excess ( i.e. low plasma level of 
renin and/or potassium with normal plasma 
aldosterone concentration. The remaining 10 
hypertensive patients were included for 
comparison because their plasma renin and 
aldosterone concentrations were known to be 
normal.
7.3. Results
Plasma concentrations of DOC, renin, 
aldosterone and potassium and also blood 
pressure are shown in Table 22,.
Plasma DOC concentration was found to 
be consistently high in 6 of the 21 patients 
with low plasma renin concentration and in 
none of the 10 in whom normal renin levels 
were found. Intermittently raised plasma DOC 
levels were found in 3 patients with low plasma 
renin concentration and in two patients with 
normal plasma renin levels. In one of the 
6 patients with consistently high DOC level, 
the estimation was repeated on the 14th day of 
treatment with dexamethasone (0,5 mg, 6 hourly)
\/
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and a similarly high result was obtained (34 ng/
100 ml before and 31 ng/lOO ml during treatment)*
In one patient DOC levels of 3.2 and 213 ng/lOO 
ml were obtained in right and left adrenal venous 
plasma respectively.
7.4. Discussion
High plasma DOC concentrations have been 
described in several syndromes with hypertension, 
hypokalaemia, suppression of renin and Inw plasma 
aldosterone levels. These include tumours 
of the adrenal cortex (Crane and Harris, 1 9 66; 
Biglieri et al, 1968; Wolff et al, I9 6 8), defects 
in either 17c^ -hydroxylation (Biglieri et al, I9 6 6; 
Goldsmith et al, 1967; Mallin I969) or lip- 
hydroxylation (Eberlein and Bongiovanni, 1956;
Imai et al, I96 8) and also ectopic corticotrophin 
syndrome (Crane and Harris, I9 6 6; Schambelan et al,
1971).
The present results appear to indicate a new 
syndrome in which hypertension is associated 
with a low plasma level of renin, normal plasma 
aldosterone concentration, a raised plasma DOC - 
concentration and hypokalaemia. High plasma DOC 
concentrations were found only in a minority of the 
low renin hypertension group and so these results
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do not necessarily conflict with findings of 
consistently normal secretion or plasma 
concentration of DOG in smaller series of similar 
patients (Woods et al, I9 6 9; Brown and Strott,
I97I; Crane et al, 1972),
Aetiology of excess DOC in hypertension.
Adrenal venography and analysis of adrenal 
venous plasma was performed in two of the six 
patients with excess plasma DOC concentration.
In one of these the appearances suggested an 
adrenocortical tumour; in the other there was 
a two-fold difference in DOC level in venous 
plasma from the two adrenal glands. More detailed 
studies are necessary in these patients.
11-hydroxy-corticosteroids and réponse to 
injected tetracosactrin were within normal range 
in all of these patients. Dexamethasone therapy 
did not alter serum electrolytes or hlood pressure 
and did not reduce plasma DOC concentration in 
one patient studied. These findings indicate that 
the mechanism involved in this syndrome is not 
corticotrophin dependent.
Role of DOC in pathogenesis
It is not apparent whether or not the levels 
of DOG noted in these subjects would be sufficiently 
high maintained over a prolonged period to cause
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the hiochemical abnormalities and hypertension. 
Successful treatment of 5 of these patients with 
spironolactone, which acts as a competitive 
inhibitor of mineralocorticoids, suggests that 
DOG may be involved in the pathogenesis. High 
plasma DOG concentration have also been 
implicated in the pathogenesis of adrenal 
regeneration hypertension (Rapp, 1969) and can 
cause hypertension in animals (Ferebee et al, 
1941; Gross et al, 1955; Hall and Hall,^196?) 
and man (Perera et al, 1944; Perera, 1948; ■ 
Reiman and Schwartz, 1952; Thorn et al, 1953).
DOG and suppression of renin.
Renin suppression is often associated with 
sodium retention (Brown et al, 1972) , The 
mechanism causing this suppression is not known. 
Despite the fact that the sodium retaining . 
potency of DOC is thought to be less than that 
of aldosterone" (Hall and Hall, I967) it is 
reasonable to expect low renin in eases of DOC 
excess,
These present results appear to indicate a 
new syndrome in patients with high blood 
pressure. However illucidation of the 
mechanism causing high plasma DOC levels, and 
determination of the extent to which this
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mineralocorticoid is responsible for the 
hypertension merits further study.
This work has been published (Broivn et 
al, 19 72) and further investigation of this 
syndrome is being conducted in our 
department.
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0 PLASMA DOC CONCENTRATION DURING NORMAL
PREGNANCY
209
8.1. Introduction
During pregnancy there is apparent need for 
sodium retention and this is partly achieved by 
increased mineralocorticoid activity. There is 
also a gradual increase in protein bound 
corticosteroids in plasma throughout pregnancy.
However, in normal and hypertensive 
, pregnancy plasma aldosterone concentration may not 
be elevated. It would appear that some other 
mineralocorticoid or mechanism is responsible 
for the increased sodium retention. The following 
study was designed in order to investigate plasma 
DOC concentration during pregnancy,
8.2, Methods and Subjects.
Plasma DOC concentration was measured in 29 
women at various stages during .pregnancy and in 
10 women in the first week post-partum.
All were single pregnancies. Ages ranged 
from 17 to 33 years (mean 24,6 years). Blood 
pressure remained normal in every case and no 
other abnormalities were observed. Blood 
samples were taken after the women had lain 
supine for 30 rains. All the women were on 
unrestricted diet.
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8.3. Hesults
Individual plasma DOC concentrations are 
shown in Table 2 3, The mean plasma 
DOC concentration was increased at 20.4 ng/lOO 
ml (range 7 .0 - 3 5.0 ).
Comparison of the mean concentration of 
plasma DOC during each trimester of pregnancy 
are shown in Table 2 3. There was no significant 
difference between stages of gestation. Çdasma 
DOC concentration fell quickly to normal in the 
puerperiura (Table 23).
8.4. Discussion
During pregnancy, plasma DOC concentration 
rises in a similar manner to plasma 11- 
hydroxycorticosteroids, The increase in 11- 
hydroxycorticosteroid concentrations during 
pregnancy is composed largely of a rise in the 
bound fraction ^probably due to a general 
increase in plasma protein concentration.
However, there is also a rise in free cortisol 
(Brown et al, 1972) indicating possibly 
stimulation by ACTE. Since DOG is also bound to 
proteins (Burke, I9 6 9) and sensitive to ACTE 
stimulation (see section 5 .3) it is possible that 
these changes also contributed to the total rise
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PLASMA DOC CONCENTRATION (ng/100 ml).
GESTATION (LTIEKS) POST-PARTUM
0 - 1 2  1 3 - 2 6  27 - Term 0 - 2  WEEKS
19.0 26.3 19.8 17.3
14.0 24.4 34.7 10.1
19.0 14.6 20,0 20.1
15.0 20.6 20.0 11.5
13.0 17.1 35.0 9.8
15.0 16.3 10.0 14.8
33.3 12.0 14.7
9.1 35.0 11.6
16.0 7.0 9.2
18.0 16,0' 6,1
15.0 11,0
2 5 .0
15.8 19,2 20.5 12.4 >IEAN
2.6 6.7 10,1 4.3 - 1 S.D.
6 11 12
..... .
n
TABLE 23.
Plasma DOC concentration during pregnancy. There 
was no significant difference in plasma DOC 
concentration between each trimester. However there 
was a significant difference between plasma DOC 
concentration during the third trimester and post­
partum levels (t = 2.3445, p <0.05).
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in plasma DOC, If bound DOG remains hormonally 
active it could conceivably contribute 
to sodium retention in pregnancy and thus an 
abnormally high concentration could possibly 
lead to hypertension particularly in a sodium 
loaded condition.
In a recent study of DOC in pregnancy 
(Brown et al, 1972) it was suggested that the 
raised maternal plasma DOC levels originate 
from the fetoplacental unit rather than ''the 
maternal adrenal cortex as dexamethasone 
administration did not suppress the maternal 
plasma DOC levels. The rapid disappearance of 
DOC from maternal plasma following delivery also 
supports this theory. These workers also found 
that in toxaemia of pregnancy .plasma DOC levels 
were as high as those found in hypertension due 
to lip hydroxylation deficiency (Brown and 
Strott, 1971). _ This suggests that DOC may play 
some role in toxaemia of pregnancy and it is 
therefore intended to extend this work to the 
study of hypertension in pregnancy.
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PLASm DOC CONCENTRATION IN SODIUM DEPLETION,
TOTAL FASTING AND REFEEDING IN OBESE SUBJECTS
214
9.1. Introduction
Previous studies (section 5 ) showed that
mild sodium depletion does not alter plasma DOC 
concentration in normal man. During the course 
of these studies the opportunity arose of studying 
a group of 4 obese subjects undergoing the more 
severe regime of total starvation as therapy 
for obesity.
9.2. Subjects and Methods
The subjects were placed on a sodium- 
restricted diet (10-20 ra.equiv./day) for 5 days, 
followed by 12 days total starvation when only, 
water was allowed to drinlc. A normal diet was then 
resumed.
At intervals throughout the study blood 
samples (50 ml.) were taken for measurement- of 
plasma concentration of renin, DOC and electrolytes 
Twenty four hour urine collections were also taken 
for measurement of urinary electrolyte excretion.
9.3. Results.
Weight.
The mean weight loss in the 4 obese subjects 
during the period of dietary sodium restriction 
was 3.4 Kg, (range 2,1 - 4,5 Kg) and during
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total fast was 7.0 Kg (range 4.5 - 9.1 Kg).
Urinary electrolyteso
Sod ium (Tab1e 24),
The mean sodium loss during 5 days of 
dietary sodium restriction was 182 ra.equiv,
(range 113-210 ra.equiv) and during 12 days of 
total fasting was 319 ra.equiv, (range 72 - 
875 ra.equiv.). The mean cumulative sodium loss 
over the period of sodium restriction and 
total fasting was 501. ra.equiv. In the ^ 
refeeding period there was marked sodium 
retention. At the end of 3 days of refeeding 
the mean cumulative sodium gain was 262 ra.equiv.
Potassium (Table 24)
During-the 5 days of sodium restriction, the 
mean cumulative potassium loss’ was 18 ra.equiv.
(range 4- 14 to - 36 ra.equiv) and during 12 days of 
total fast was 428 ra.equiv (range 371 “ 490 ra.equiv.)
In the first” 3 duys of refeeding, the mean 
cumulative potassium gain was 57 ra.equiv. (11 - 
82 ra.equiv).
Plasma renin concentration.
At the end of 5 days of sodium deprivation 
plasma renin concentration rose in all 4 
subjects (Table 25). In the first few days of
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Sodium depletion 
Cumulative loss
Total Fast 
Cumulative 
loss
Refeeding
Cumulative
gain
Mean Range Mean Range Mean Range
Na 182 113 - 319 72 - 475 406 -
210 . 875 510
K ' 18 14 - 428 371 100 46 -
36 490 135
TABLE 24
Cumulative changes in urinary electrolyte excretion 
(ra.equiv.) during sodium depletion, total . 
fasting and refeeding in obese subjects.
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Day A B C D
1 10.3 10.2 16.0 6.8
6 20.6 14.8 22.8 . 1 7 .6
7 18 .3 29.2 11.2 11.5
8 16.3 25.5 24.7 9.7
9 — 2 7 .0 1 8 .6 9.7
14 17.6 16.2 25.7 - 16.3
15 — 42.5 19.9 18.2
18 92 60.7 1 7 .9 19.8
20 40.3 52.5 1 7 .9 2 1 .3
22 22,8 2 7 .7 1 4 .4 8.5
TABLE 25.
Plasma renin concentration (units/litre) during 
sodium depletion, total fasting and refeeding 
in obese subjects.
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total fast; plasma renin fell, rising 
again towards the end of the period of total 
fast. During the refeeding period plasma renin 
concentration again fell rapidly.
Plasma DOC concentration
At the end of the period of dietary sodium 
restriction plasma DOC concentration rose 
in all four subjects. During the period of 
total fast it fell rapidly to very low levels 
below the normal range (Figure 18, Table 35).
In the refeeding period plasma DOC rose 
towards or above the normal range.
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P L A S M A .
DOC ngAûOml  
50 r
N a *  DE PR IV ATI ON V O T A I  F A S T I N G
40
30
N O R M A L  R A N G E
t
DAYS
FIGURE 18
Plasma DOC concentration (ng/lOO ml) in obese 
subjects during sodium deprivation, total lasting 
and refeeding. .
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9.4, Discussion
1. Effects of sodium depletion.
In this study the mean cumulative sodium loss 
(182 m.equiv,) was considerably greater than that 
achieved by sodium depletion of normal subjects 
(section 5.5), This may be due to the effect of 
the lower sodium content of this diet used in this 
present study (10-20 m.equiv,) compared with that 
used in the previous study of normal subjects and 
to the effect of the weight loss of the obese 
subjects.
During the period of sodium depletion plasma 
renin rose in all 4 subjects. This indicates 
that the renin angiotensin system would be activated 
and as a result aldosterone secretion would 
probably be raised although it was not measured 
in this case. However, the relationships of 
renin and aldosterone is known to be valid in 
obese subjects (Chinn et al, 1970).
Plasma DOC concentration rose during sodium 
depletion in contrast to the results of sodium 
depletion in normal subjects (section 5.5). It is 
not clear whether this difference is due to the 
effects of greater sodium loss or to some 
particular endocrinological aberration in obesity. 
For example distinguishing between obesity and
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Cushing's syndrome by adrenal function tests 
occasionally proves difficult as obese subjects 
may have high resting corticosteroid levels.
The ACTH secreting mechanism is more sensitive 
in obese subjects although this does not cause 
a rise in cortisol (Chihn et al, 1970), However, 
DOG may be marginally more sensitive than cortisol 
to ACTH,
Renin-DOC relationship
Angiotensin II infusion in normal Subjects 
does not increase plasma DOC concentration. This 
means that either there is no relationship between 
the increase in plasma renin concentration and the 
increase in plasma DOG concentration or some 
mechanism peculiar to obese subjects is 
responsible for these changes.in renin and DOC, 
Further study is obviously required to investigate 
this point,
II. Effects of total starvation.
It has been shown that plasma aldosterone 
concentration rises during total starvation as a 
result of sodium depletion (Chinn et al, 1970) 
However, there is a temporary fall in renin 
associated with a diuresis when calorie intake 
is reduced to zero. This dissociation of renin 
and aldosterone is discussed by Chinn et al (1970)
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The 4 subjects continued to lose sodium and 
at the end of the period of starvation were much 
more severely sodium depleted than after 
uncomplicated sodium depletion.
Total starvation causes a fall in blood 
glucose which, as in the insulin stress test, 
is an effective stress stimulus. However,
Chinn et al (1970) found no change in plasma 
cortisol during fasting.
Plasma DOC concentration falls to low levels 
during total starvation while plasma aldosterone 
concentration rises (Chinn et al, 1970 ) . This 
may be due to an increased efficiency of lip 
of 18 hydroxylation of DOG, This could not be 
caused by stimulation by angiotensin II as the 
concentrations of renin and therefore of 
angiotensin are low. In any case angiotensin II 
acts early in the biosynthesis of aldosterone 
during the conversion of cholesterol to 
pregnenolone (-Huiler, 197o). The decrease in 
DOC concentration and simultaneous increase in 
plasma aldosterone concentration may be due 
to some unknown factor acting on the 
biosynthetic pathway between DOC and aldosterone. 
Study of corticosterone and 18-hydroxycorticosterone
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would be necessary to ascertain the extent of the 
impairment of secretion,
III, Refeeding.
Sodium retention occurred rapidly during the 
period of refeeding (475 m.equiv,) and plasma 
DOC concentration quickly attained pre-treatment 
levels.
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10, GENERAL CONCLUSIONS
225
10, GENERAL CONCLUSION
Techniques, The development of new techniques
and methods of assay of steroid hormones has 
provided a quantitative basis for study of the 
role of the adrenal cortex in health and disease. 
The discovery of new disease situations such as 
Conn's syndrome has followed the development of 
methods of measuring plasma concentrations or 
secretion rates of aldosterone and other^ 
corticosteroids. In the present work methods of 
measuring the plasma concentration of DOC have 
been developed and compared and these methods 
have been instrumental in the discovery of an • 
apparently new syndrome in which hypertension is 
associated with low plasma concentrations of renin 
and angiotensin II, normal plasma aldosterone 
concentration, raised plasma DOC concentration and 
intermittent or persistent hypokalaemia.
Methods developed for the analysis of large 
numbers of samples need to be convenient, precise 
and highly specific. The gas liquid 
chromatographic method and radioimmunoassay are 
convenient and precise. However, the gas-liquid 
chromatographic method is more specific and would 
be the method of choice for analysis of unknown 
samples or samples from patients who have been
226
prescribed steroid drugs such as spironolactone.
The specificity of the radioimmunoassay, which 
gave results comparable to the gas liquid 
chromatographic method, can not be assumed in 
such a situation where unknown drug metabolites 
may be present. Both methods possess high 
sensitivity adequate for analysis of human plasma 
and also small volumes of whole blood in animal 
studies. This has proved to be of particular 
benefit in the study of hypertension in the rat 
where the level of blood pressure attained can 
now be compared with the concentration of DOG 
prevailing in whole blood at that time.
Application of electron capture detection of 
steroids to analysis of biological samples has until 
recently been hindered by the problem of contamination 
of the detector. The introduction of a by-pass 
valve into the gas chromatograph has greatly increased 
the applicability and sensitivity of the technique 
for analysis of biological extracts by overcoming 
the problem of detector contamination.
Obviously, there is yet great scope for 
improvement of these techniques. For example, use 
of capillary columns coated with stationary 
phase would improve the quality of the chromatography 
and minimise column bleed.
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This may improve the sensitivity of the GLC 
method by minimising losses due to column 
absorption.
In the techniques of radioimmunoassay, more 
specific antisera are yet required in order that 
prior extraction and chromatography of sample 
may be omitted. The more successful means of 
achieving the end may not be the improvement of 
immunisation procedure and techniques but 
purification and isolation of particular^ antibodies 
in antisera presently in use.
10. Control of DOC secretion.
DOC is secreted by the adrenal cortex as a 
result of stimulation by ACTH and is in a true 
sense a secretory product of the gland. Present 
findings indicate that DOC secretion is controlled 
mainly by ACTH in contrast to aldosterone which 
is governed mainly by the renin angiotensin 
system. Moderate electrolyte changes due to 
dietary sodium depletion does not alter plasma 
DOG concentration in normal subjects, although 
in obese subjects this produces an increase in 
plasma DOC concentration. DOC is to some
C
extent bound to plasma.proteins such as albumen 
or corticosteroid binding globulin and as a 
result raised plasma DOC concentration is
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found in conditions such as pregnancy inhere there 
is an increase in plasma protein concentration.
Role of DOC in sodium retention.
DOC is thought to he a much less potent 
mineralocorticoid than aldosterone in man (Hall 
and Hall, 19^7) and as it is found iq. plasma in 
similar concentrations to aldosterone it is 
assumed that DOC does not play a major role in 
normal electrolyte and water balance but 
probably contributes to the overall conbrol.
However, the evidence that DOC is a less potent 
mineralocorticoid than aldosterone is not 
conclusive as no controlled pharmacological studies 
has been done in normal man.
Role of DOC in pathogenesis of hypertension
In this present study raised plasma DOC levels 
have been found in patients with hypertension. 
Whether the levels of DOC measured in these subjects 
would be sufficient to raise blood pressure and 
cause the electrolyte abnormalities has yet to be 
established. However it is known that DOC will 
correct the electrolyte abnormalities associated 
with Addison's disease. Also in nephrectoraised 
rats given saline as drinking water DOGA injections 
given frequently will induce severe 
hypertension.
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Fu r t h e r Studies.
Investigation of the control of electrolyte 
and water homeostasis in man requires a knowledge 
not only of the behaviour of each individual 
mineralocorticoid but also an understanding of 
their relationship and relative contribution 
to this total control. The development of gas 
liquid chromatographic techniques for 
measurement of all the known mineralocorticoids 
(Mason, 1973) using a small volume of plasma 
is in progress and may prove useful in the 
investigation of patients with hypertension 
presumably due to excess of one or more 
mineralocorticoids in plasma.
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